# pathway_nodes

date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 321.59
first_seen: 2025-02-14T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-14
last_seen_parent: 2025-12-29
average_administered: [7.08, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 7.1 times with a 1.9 weekly interval (13.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 816.6
first_seen: 2025-03-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-10
last_seen_parent: 2025-12-31
average_administered: [1.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.8 times with a 0.1 weekly interval (0.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 5810.91
first_seen: 2025-02-19T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-19
last_seen_parent: 2025-12-31
average_administered: [3.0476190476190474, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.0 times with a 5.7 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 9944.93
first_seen: 2025-07-11T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2025-07-11
last_seen_parent: 2025-12-23
average_administered: [1.6666666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 1.7 times with a 2.4 weekly interval (4.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2495.43
first_seen: 2025-02-13T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-13
last_seen_parent: 2025-12-30
average_administered: [3.375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 3.4 times with a 6.6 weekly interval (22.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: OBINUTUZUMAB
cost_pp_pa: 38784.5
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-31
average_administered: [8.133333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: OBINUTUZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OBINUTUZUMAB</b><br>On average given 8.1 times with a 2.0 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: RITUXIMAB
cost_pp_pa: 5348.67
first_seen: 2025-02-07T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-07
last_seen_parent: 2025-12-31
average_administered: [9.035714285714286, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9.0 times with a 1.4 weekly interval (13.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: ACALABRUTINIB
cost_pp_pa: 53933.63
first_seen: 2025-02-13T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2025-02-13
last_seen_parent: 2025-12-15
average_administered: [4.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 4.4 times with a 3.1 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: IMMUNOGLOBULIN
cost_pp_pa: 36387.97
first_seen: 2025-02-21T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2025-02-21
last_seen_parent: 2025-09-25
average_administered: [5.538461538461538, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 5.5 times with a 1.4 weekly interval (8.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: DOCETAXEL
cost_pp_pa: 1320.08
first_seen: 2025-05-16T00:00:00
last_seen: 2025-10-15T00:00:00
first_seen_parent: 2025-05-16
last_seen_parent: 2025-10-15
average_administered: [3.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - DOCETAXEL

average_spacing:
<br><b>DOCETAXEL</b><br>On average given 3.2 times with a 2.1 weekly interval (7.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 6470.11
first_seen: 2025-03-28T00:00:00
last_seen: 2025-11-19T00:00:00
first_seen_parent: 2025-03-28
last_seen_parent: 2025-11-19
average_administered: [4.444444444444445, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 4.4 times with a 3.1 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 23390.89
first_seen: 2025-02-18T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-18
last_seen_parent: 2025-12-30
average_administered: [5.923076923076923, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 5.9 times with a 3.3 weekly interval (19.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 7713.22
first_seen: 2025-06-13T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-06-13
last_seen_parent: 2025-12-29
average_administered: [1.3125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 1.3 times with a 1.1 weekly interval (1.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 13395.28
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-18
average_administered: [2.347826086956522, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 2.3 times with a 8.1 weekly interval (19.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 6245.55
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-30
average_administered: [3.4482758620689653, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 3.4 times with a 5.1 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - BREAST SURGERY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - BREAST SURGERY - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1324.88
first_seen: 2025-02-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-11
last_seen_parent: 2025-12-31
average_administered: [3.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: BREAST SURGERY
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 3.5 times with a 2.6 weekly interval (9.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 4610.35
first_seen: 2025-02-20T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-20
last_seen_parent: 2025-12-31
average_administered: [4.975609756097561, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.0 times with a 2.7 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: INFLIXIMAB
cost_pp_pa: 6315.73
first_seen: 2025-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-12
last_seen_parent: 2025-12-30
average_administered: [4.3816793893129775, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.4 times with a 3.4 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: BEVACIZUMAB
cost_pp_pa: 678.84
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-31
average_administered: [1.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 1.5 times with a 5.4 weekly interval (8.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: AFLIBERCEPT
cost_pp_pa: 7938.9
first_seen: 2025-02-06T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-02
average_administered: [3.2238805970149254, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.2 times with a 4.3 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - IMMUNOGLOBULIN
labels: IMMUNOGLOBULIN
cost_pp_pa: 178799.01
first_seen: 2025-02-06T00:00:00
last_seen: 2025-09-08T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-09-08
average_administered: [4.764705882352941, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 4.8 times with a 1.0 weekly interval (5.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
labels: DIMETHYL FUMARATE
cost_pp_pa: 204.67
first_seen: 2025-04-10T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2025-04-10
last_seen_parent: 2025-12-15
average_administered: [3.1666666666666665, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: DIMETHYL FUMARATE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - DIMETHYL FUMARATE

average_spacing:
<br><b>DIMETHYL FUMARATE</b><br>On average given 3.2 times with a 2.4 weekly interval (8.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1985.26
first_seen: 2025-02-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-07
last_seen_parent: 2025-12-30
average_administered: [5.566037735849057, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.6 times with a 6.7 weekly interval (38.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 1633.77
first_seen: 2025-07-24T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2025-07-24
last_seen_parent: 2025-12-17
average_administered: [1.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 1.6 times with a 2.4 weekly interval (4.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4952.94
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-31
average_administered: [3.864864864864865, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.9 times with a 6.1 weekly interval (24.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 4499.79
first_seen: 2025-02-25T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2025-02-25
last_seen_parent: 2025-12-24
average_administered: [2.0555555555555554, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.1 times with a 4.0 weekly interval (8.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3140.52
first_seen: 2025-03-06T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-12-24
average_administered: [3.3, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 3.3 times with a 3.9 weekly interval (13.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
labels: IMMUNOGLOBULIN
cost_pp_pa: 95675.5
first_seen: 2025-03-26T00:00:00
last_seen: 2025-09-03T00:00:00
first_seen_parent: 2025-03-26
last_seen_parent: 2025-09-03
average_administered: [5.428571428571429, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 5.4 times with a 1.1 weekly interval (6.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - FILGOTINIB
labels: FILGOTINIB
cost_pp_pa: 3562.85
first_seen: 2025-03-17T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2025-03-17
last_seen_parent: 2025-12-22
average_administered: [4.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FILGOTINIB</b><br>On average given 4.0 times with a 3.4 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 5980.16
first_seen: 2025-03-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-03-04
last_seen_parent: 2025-12-30
average_administered: [4.466666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4.5 times with a 3.7 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 10329.37
first_seen: 2025-04-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-12
last_seen_parent: 2025-12-30
average_administered: [4.04, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.0 times with a 3.9 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 4376.57
first_seen: 2025-02-28T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-28
last_seen_parent: 2025-12-31
average_administered: [3.5454545454545454, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.5 times with a 4.0 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 6859.9
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-31
average_administered: [4.191082802547771, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 4.2 times with a 4.0 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 23462.69
first_seen: 2025-03-28T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2025-03-28
last_seen_parent: 2025-12-18
average_administered: [4.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 4.0 times with a 3.1 weekly interval (13.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1512.45
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-29
average_administered: [4.552631578947368, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 4.6 times with a 2.6 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 8243.66
first_seen: 2025-02-27T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-27
last_seen_parent: 2025-12-31
average_administered: [7.857142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 7.9 times with a 2.1 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 3802.29
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-31
average_administered: [10.086206896551724, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 10.1 times with a 1.3 weekly interval (13.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 1173.97
first_seen: 2024-04-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-08
last_seen_parent: 2025-12-30
average_administered: [3.1666666666666665, 6.166666666666667, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB - BEVACIZUMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.2 times with a 6.7 weekly interval (21.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 6.2 times with a 1.0 weekly interval (6.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB - UPADACITINIB
labels: UPADACITINIB
cost_pp_pa: 4066.65
first_seen: 2024-06-13T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-03-01
last_seen_parent: 2025-12-31
average_administered: [3.0, 3.0, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.0 times with a 7.0 weekly interval (21.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 3.0 times with a 8.6 weekly interval (26.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: 2608.81
first_seen: 2024-06-12T00:00:00
last_seen: 2025-11-30T00:00:00
first_seen_parent: 2024-04-08
last_seen_parent: 2025-11-30
average_administered: [3.142857142857143, 3.4285714285714284, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.1 times with a 5.3 weekly interval (16.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 3.4 times with a 6.4 weekly interval (22.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 2709.29
first_seen: 2024-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-12-30
average_administered: [4.377777777777778, 4.6, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.4 times with a 12.4 weekly interval (55.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 4.6 times with a 9.3 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 2992.0
first_seen: 2024-02-21T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2024-02-21
last_seen_parent: 2025-12-08
average_administered: [3.5, 3.5, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.5 times with a 14.9 weekly interval (52.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 3.5 times with a 7.1 weekly interval (25.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ETANERCEPT
cost_pp_pa: 3013.23
first_seen: 2024-04-10T00:00:00
last_seen: 2025-12-03T00:00:00
first_seen_parent: 2024-04-10
last_seen_parent: 2025-12-09
average_administered: [2.7142857142857144, 5.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB - ETANERCEPT

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.7 times with a 10.7 weekly interval (29.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 5.0 times with a 5.4 weekly interval (27.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 2124.37
first_seen: 2024-02-28T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-02-28
last_seen_parent: 2025-12-19
average_administered: [5.166666666666667, 1.8333333333333333, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.2 times with a 10.9 weekly interval (56.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 1.8 times with a 6.9 weekly interval (12.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 8221.8
first_seen: 2024-02-15T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-17
average_administered: [4.125, 4.5, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.1 times with a 5.3 weekly interval (22.0 weeks total treatment length)<br><b>RISANKIZUMAB</b><br>On average given 4.5 times with a 11.1 weekly interval (50.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 7170.39
first_seen: 2024-04-24T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-04-24
last_seen_parent: 2025-12-23
average_administered: [5.25, 3.25, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.2 times with a 10.7 weekly interval (56.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 3.2 times with a 8.9 weekly interval (28.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3725.29
first_seen: 2024-02-09T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2024-02-09
last_seen_parent: 2025-12-08
average_administered: [7.5, 4.5, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 7.5 times with a 6.6 weekly interval (49.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 4.5 times with a 4.3 weekly interval (19.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2775.96
first_seen: 2024-10-02T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2024-10-02
last_seen_parent: 2025-12-18
average_administered: [5.2, 3.6, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5.2 times with a 4.0 weekly interval (21.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 3.6 times with a 4.1 weekly interval (15.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 5175.85
first_seen: 2024-02-26T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-23
average_administered: [5.8, 3.6, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5.8 times with a 6.1 weekly interval (36.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 3.6 times with a 5.9 weekly interval (21.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 2663.56
first_seen: 2024-02-26T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-31
average_administered: [4.216666666666667, 5.433333333333334, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.2 times with a 11.7 weekly interval (49.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 5.4 times with a 6.4 weekly interval (35.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ETANERCEPT
cost_pp_pa: 3060.85
first_seen: 2024-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-12-30
average_administered: [3.9, 6.9, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.9 times with a 6.4 weekly interval (25.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 6.9 times with a 3.9 weekly interval (27.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1893.26
first_seen: 2024-04-16T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-16
last_seen_parent: 2025-12-29
average_administered: [5.461538461538462, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.5 times with a 8.4 weekly interval (46.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 8720.97
first_seen: 2024-04-08T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-08
last_seen_parent: 2025-12-29
average_administered: [18.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 18.5 times with a 3.4 weekly interval (63.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - UPADACITINIB
labels: UPADACITINIB
cost_pp_pa: 4923.1
first_seen: 2024-02-22T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-21
last_seen_parent: 2025-12-30
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>UPADACITINIB</b><br>On average given 5.0 times with a 14.6 weekly interval (73.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3416.69
first_seen: 2024-10-17T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-29
average_administered: [3.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 3.5 times with a 8.1 weekly interval (28.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4178.73
first_seen: 2024-03-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-03-04
last_seen_parent: 2025-12-31
average_administered: [4.48, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.5 times with a 7.4 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: ACALABRUTINIB
cost_pp_pa: 35908.49
first_seen: 2024-05-08T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2024-05-08
last_seen_parent: 2025-12-08
average_administered: [7.133333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 7.1 times with a 9.9 weekly interval (70.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1706.74
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-29
average_administered: [6.8076923076923075, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.8 times with a 10.1 weekly interval (69.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 8448.26
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-29
average_administered: [6.038461538461538, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 6.0 times with a 8.1 weekly interval (49.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2756.99
first_seen: 2024-06-27T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-10
last_seen_parent: 2025-12-29
average_administered: [5.888888888888889, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.9 times with a 8.6 weekly interval (51.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3777.15
first_seen: 2024-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-14
last_seen_parent: 2025-12-31
average_administered: [6.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.8 times with a 5.4 weekly interval (37.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1790.88
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [8.876712328767123, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.9 times with a 7.7 weekly interval (69.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 10977.46
first_seen: 2024-03-01T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2024-03-01
last_seen_parent: 2025-12-18
average_administered: [4.363636363636363, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 4.4 times with a 10.4 weekly interval (46.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 5505.0
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [7.05, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 7.0 times with a 4.9 weekly interval (34.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3318.51
first_seen: 2024-04-30T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-04-10
last_seen_parent: 2025-12-24
average_administered: [6.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.5 times with a 5.1 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 970.77
first_seen: 2024-02-15T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-24
average_administered: [2.9285714285714284, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.9 times with a 14.7 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 6254.64
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-29
average_administered: [7.571428571428571, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 7.6 times with a 8.1 weekly interval (62.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 11022.83
first_seen: 2024-08-07T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-29
average_administered: [7.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 7.3 times with a 4.4 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: INFLIXIMAB
cost_pp_pa: 4213.84
first_seen: 2024-02-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-08
last_seen_parent: 2025-12-30
average_administered: [6.9689119170984455, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7.0 times with a 4.9 weekly interval (34.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: VEDOLIZUMAB
cost_pp_pa: 15340.05
first_seen: 2024-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-14
last_seen_parent: 2025-12-31
average_administered: [7.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 7.3 times with a 6.0 weekly interval (44.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: RANIBIZUMAB
cost_pp_pa: 2020.09
first_seen: 2024-02-06T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-31
average_administered: [4.447916666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.4 times with a 6.4 weekly interval (28.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: AFLIBERCEPT
cost_pp_pa: 4792.53
first_seen: 2024-02-26T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-23
average_administered: [4.927710843373494, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.9 times with a 7.0 weekly interval (34.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: BEVACIZUMAB
cost_pp_pa: 1028.17
first_seen: 2024-08-07T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-08-07
last_seen_parent: 2025-12-31
average_administered: [2.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.0 times with a 10.1 weekly interval (20.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4098.65
first_seen: 2024-06-05T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2024-06-05
last_seen_parent: 2025-12-23
average_administered: [4.428571428571429, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 4.4 times with a 4.3 weekly interval (19.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 15924.77
first_seen: 2024-11-29T00:00:00
last_seen: 2025-11-20T00:00:00
first_seen_parent: 2024-04-22
last_seen_parent: 2025-11-21
average_administered: [3.142857142857143, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 3.1 times with a 9.7 weekly interval (30.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - UPADACITINIB
labels: UPADACITINIB
cost_pp_pa: 8285.87
first_seen: 2024-05-09T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-05-09
last_seen_parent: 2025-12-31
average_administered: [4.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>UPADACITINIB</b><br>On average given 4.0 times with a 7.3 weekly interval (29.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2395.37
first_seen: 2024-02-21T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-23
average_administered: [6.614285714285714, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.6 times with a 9.1 weekly interval (60.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 4111.04
first_seen: 2024-11-18T00:00:00
last_seen: 2025-11-20T00:00:00
first_seen_parent: 2024-11-18
last_seen_parent: 2025-11-20
average_administered: [3.142857142857143, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 3.1 times with a 12.1 weekly interval (38.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 3230.85
first_seen: 2024-04-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-30
average_administered: [6.1, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 6.1 times with a 9.4 weekly interval (58.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2836.49
first_seen: 2024-02-21T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-21
last_seen_parent: 2025-12-31
average_administered: [6.433333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.4 times with a 8.6 weekly interval (55.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 6583.75
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-31
average_administered: [7.457142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7.5 times with a 4.4 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 6550.37
first_seen: 2024-02-22T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-22
last_seen_parent: 2025-12-30
average_administered: [6.111111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 6.1 times with a 6.9 weekly interval (42.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 17710.47
first_seen: 2024-03-01T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-03-01
last_seen_parent: 2025-12-31
average_administered: [8.357142857142858, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 8.4 times with a 5.3 weekly interval (44.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1714.88
first_seen: 2024-04-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-17
last_seen_parent: 2025-12-30
average_administered: [4.8125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.8 times with a 11.0 weekly interval (53.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - APREMILAST
labels: APREMILAST
cost_pp_pa: 6843.94
first_seen: 2024-09-02T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2024-09-02
last_seen_parent: 2025-12-15
average_administered: [5.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>APREMILAST</b><br>On average given 5.2 times with a 6.7 weekly interval (35.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 9388.93
first_seen: 2024-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-12-30
average_administered: [3.9473684210526314, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 3.9 times with a 10.6 weekly interval (41.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 5210.37
first_seen: 2024-02-15T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-16
average_administered: [10.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 10.0 times with a 4.3 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: ADALIMUMAB
cost_pp_pa: 2141.85
first_seen: 2024-02-13T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-13
last_seen_parent: 2025-12-30
average_administered: [9.285714285714286, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.3 times with a 8.1 weekly interval (76.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4799.72
first_seen: 2024-04-21T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-21
last_seen_parent: 2025-12-30
average_administered: [5.051282051282051, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.1 times with a 6.0 weekly interval (31.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1526.6
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [4.7827586206896555, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.8 times with a 8.9 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1690.4
first_seen: 2024-02-29T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-29
last_seen_parent: 2025-12-29
average_administered: [5.0144927536231885, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.0 times with a 10.7 weekly interval (54.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3814.7
first_seen: 2024-02-29T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-24
average_administered: [6.142857142857143, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6.1 times with a 6.9 weekly interval (42.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1696.39
first_seen: 2024-10-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-10-02
last_seen_parent: 2025-12-30
average_administered: [3.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 3.6 times with a 11.7 weekly interval (42.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY
labels: ALIROCUMAB
cost_pp_pa: 2357.57
first_seen: 2024-02-13T00:00:00
last_seen: 2025-12-09T00:00:00
first_seen_parent: 2024-02-13
last_seen_parent: 2025-12-09
average_administered: [10.222222222222221, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY
drug_sequence: ALIROCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY - ALIROCUMAB

average_spacing:
<br><b>ALIROCUMAB</b><br>On average given 10.2 times with a 6.9 weekly interval (70.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY
labels: EVOLOCUMAB
cost_pp_pa: 2132.55
first_seen: 2024-03-18T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-03-18
last_seen_parent: 2025-12-30
average_administered: [8.818181818181818, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY
drug_sequence: EVOLOCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>EVOLOCUMAB</b><br>On average given 8.8 times with a 6.7 weekly interval (59.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2278.85
first_seen: 2024-02-20T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-20
last_seen_parent: 2025-12-29
average_administered: [5.428571428571429, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.4 times with a 9.3 weekly interval (50.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3365.58
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-31
average_administered: [6.248366013071895, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 6.2 times with a 9.0 weekly interval (56.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 1856.86
first_seen: 2024-03-07T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2024-02-09
last_seen_parent: 2025-12-18
average_administered: [2.857142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.9 times with a 10.9 weekly interval (31.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4265.83
first_seen: 2024-02-09T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-09
last_seen_parent: 2025-12-31
average_administered: [5.890829694323144, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.9 times with a 5.9 weekly interval (35.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 4895.36
first_seen: 2024-10-25T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-10-25
last_seen_parent: 2025-12-31
average_administered: [2.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.0 times with a 2.6 weekly interval (5.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 5800.81
first_seen: 2024-04-12T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-12
last_seen_parent: 2025-12-29
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.0 times with a 6.9 weekly interval (34.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2629.48
first_seen: 2024-02-12T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-09-25
average_administered: [3.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 3.9 times with a 20.9 weekly interval (81.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 4437.1
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-31
average_administered: [1.8421052631578947, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.8 times with a 18.4 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1254.96
first_seen: 2024-02-12T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-12-19
average_administered: [3.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.5 times with a 5.9 weekly interval (20.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 7261.19
first_seen: 2025-01-25T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-12-02
last_seen_parent: 2025-12-30
average_administered: [2.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 2.5 times with a 4.0 weekly interval (10.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 834.53
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-30
average_administered: [4.769230769230769, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4.8 times with a 8.1 weekly interval (39.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1880.23
first_seen: 2024-02-08T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-08
last_seen_parent: 2025-12-31
average_administered: [5.178947368421053, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.2 times with a 10.3 weekly interval (53.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4359.05
first_seen: 2024-06-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-06-04
last_seen_parent: 2025-12-31
average_administered: [6.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6.6 times with a 12.0 weekly interval (79.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 3570.35
first_seen: 2024-07-10T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-07-10
last_seen_parent: 2025-11-26
average_administered: [14.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL IMMUNOLOGY
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 14.2 times with a 3.0 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1496.78
first_seen: 2024-02-22T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2024-02-22
last_seen_parent: 2025-11-26
average_administered: [4.958333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.0 times with a 8.4 weekly interval (42.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3644.1
first_seen: 2024-02-21T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-02-21
last_seen_parent: 2025-11-26
average_administered: [9.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 9.0 times with a 7.7 weekly interval (69.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 21415.45
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-30
average_administered: [11.108695652173912, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 11.1 times with a 3.4 weekly interval (38.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 3464.48
first_seen: 2024-09-24T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-09-24
last_seen_parent: 2025-12-29
average_administered: [11.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 11.0 times with a 2.6 weekly interval (28.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 2663.34
first_seen: 2024-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-12-30
average_administered: [4.224489795918367, 4.612244897959184, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.2 times with a 12.3 weekly interval (52.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 4.6 times with a 8.7 weekly interval (40.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
labels: UPADACITINIB
cost_pp_pa: 7182.77
first_seen: 2024-03-28T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2024-03-28
last_seen_parent: 2025-11-25
average_administered: [2.6666666666666665, 6.333333333333333, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB - UPADACITINIB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 2.7 times with a 2.6 weekly interval (7.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 6.3 times with a 7.9 weekly interval (49.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 7171.88
first_seen: 2024-04-24T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-04-24
last_seen_parent: 2025-12-23
average_administered: [4.8, 3.0, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.8 times with a 12.6 weekly interval (60.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 3.0 times with a 7.0 weekly interval (21.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 2664.71
first_seen: 2024-02-26T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-31
average_administered: [4.174603174603175, 5.4603174603174605, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.2 times with a 12.3 weekly interval (52.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 5.5 times with a 6.4 weekly interval (35.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
labels: BEVACIZUMAB
cost_pp_pa: 2080.55
first_seen: 2024-03-01T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2024-03-01
last_seen_parent: 2025-12-22
average_administered: [4.4, 2.6, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT - BEVACIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.4 times with a 9.4 weekly interval (41.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 2.6 times with a 8.3 weekly interval (22.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
labels: FARICIMAB
cost_pp_pa: 5348.58
first_seen: 2024-02-26T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-23
average_administered: [5.909090909090909, 3.3636363636363638, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5.9 times with a 6.1 weekly interval (36.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 3.4 times with a 5.3 weekly interval (18.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4217.74
first_seen: 2024-03-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-03-04
last_seen_parent: 2025-12-31
average_administered: [4.103448275862069, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.1 times with a 7.4 weekly interval (30.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3771.45
first_seen: 2024-07-30T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-29
average_administered: [3.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 3.9 times with a 7.3 weekly interval (28.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1679.01
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-29
average_administered: [6.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.6 times with a 10.3 weekly interval (68.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 8685.31
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-29
average_administered: [5.933333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 5.9 times with a 7.9 weekly interval (46.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2961.89
first_seen: 2024-02-12T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-09-25
average_administered: [3.769230769230769, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 3.8 times with a 16.7 weekly interval (64.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: DEXAMETHASONE
cost_pp_pa: 5569.19
first_seen: 2024-09-15T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-08-29
last_seen_parent: 2025-12-31
average_administered: [2.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - DEXAMETHASONE

average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 2.4 times with a 18.3 weekly interval (44.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4230.64
first_seen: 2024-06-05T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2024-06-05
last_seen_parent: 2025-12-23
average_administered: [4.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 4.0 times with a 3.7 weekly interval (15.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 11163.45
first_seen: 2024-03-01T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2024-03-01
last_seen_parent: 2025-12-18
average_administered: [4.166666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 4.2 times with a 10.6 weekly interval (44.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 5682.88
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [6.681818181818182, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6.7 times with a 4.9 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3243.82
first_seen: 2024-04-30T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-04-10
last_seen_parent: 2025-12-24
average_administered: [6.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.0 times with a 5.1 weekly interval (31.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1230.23
first_seen: 2024-02-15T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-24
average_administered: [2.8484848484848486, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.8 times with a 11.9 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1803.97
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [8.741228070175438, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.7 times with a 7.7 weekly interval (67.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 10664.59
first_seen: 2024-02-19T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-19
last_seen_parent: 2025-12-29
average_administered: [8.304347826086957, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 8.3 times with a 4.6 weekly interval (38.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: ADALIMUMAB
cost_pp_pa: 2104.85
first_seen: 2024-02-13T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-13
last_seen_parent: 2025-12-30
average_administered: [8.956521739130435, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.0 times with a 8.1 weekly interval (73.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY
labels: ALIROCUMAB
cost_pp_pa: 2391.27
first_seen: 2024-02-13T00:00:00
last_seen: 2025-12-09T00:00:00
first_seen_parent: 2024-02-13
last_seen_parent: 2025-12-09
average_administered: [9.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY
drug_sequence: ALIROCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ALIROCUMAB</b><br>On average given 9.6 times with a 6.4 weekly interval (62.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: VEDOLIZUMAB
cost_pp_pa: 15334.95
first_seen: 2024-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-14
last_seen_parent: 2025-12-31
average_administered: [6.9523809523809526, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 7.0 times with a 6.4 weekly interval (45.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: AFLIBERCEPT
cost_pp_pa: 4805.95
first_seen: 2024-02-26T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-23
average_administered: [4.8474576271186445, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.8 times with a 6.7 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: BEVACIZUMAB
cost_pp_pa: 901.48
first_seen: 2024-03-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-03-28
last_seen_parent: 2025-12-31
average_administered: [1.9189189189189189, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 1.9 times with a 9.3 weekly interval (18.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
labels: RANIBIZUMAB
cost_pp_pa: 1853.24
first_seen: 2024-02-06T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-31
average_administered: [4.311572700296736, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.3 times with a 6.6 weekly interval (28.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2366.96
first_seen: 2024-02-16T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-23
average_administered: [6.680555555555555, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.7 times with a 9.1 weekly interval (61.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2847.9
first_seen: 2024-02-21T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-21
last_seen_parent: 2025-12-31
average_administered: [6.338709677419355, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.3 times with a 8.4 weekly interval (53.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 6707.41
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-31
average_administered: [7.1891891891891895, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7.2 times with a 4.3 weekly interval (31.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 17889.35
first_seen: 2024-03-01T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-03-01
last_seen_parent: 2025-12-31
average_administered: [8.266666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 8.3 times with a 5.1 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - APREMILAST
labels: APREMILAST
cost_pp_pa: 7027.01
first_seen: 2024-09-02T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2024-09-02
last_seen_parent: 2025-12-15
average_administered: [4.666666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>APREMILAST</b><br>On average given 4.7 times with a 5.6 weekly interval (26.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 9452.48
first_seen: 2024-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-12-30
average_administered: [4.048780487804878, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 4.0 times with a 10.0 weekly interval (40.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 5075.83
first_seen: 2024-02-15T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-16
average_administered: [9.409090909090908, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 9.4 times with a 4.6 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2428.64
first_seen: 2024-02-20T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-20
last_seen_parent: 2025-12-29
average_administered: [5.5344827586206895, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.5 times with a 9.1 weekly interval (50.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY
labels: INFLIXIMAB
cost_pp_pa: 4310.07
first_seen: 2024-02-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-08
last_seen_parent: 2025-12-30
average_administered: [6.581818181818182, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.6 times with a 4.9 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 1955.28
first_seen: 2024-03-07T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2024-02-09
last_seen_parent: 2025-12-18
average_administered: [2.625, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.6 times with a 9.4 weekly interval (25.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4289.76
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-31
average_administered: [5.826923076923077, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.8 times with a 5.9 weekly interval (34.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3749.02
first_seen: 2024-02-29T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-24
average_administered: [6.125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6.1 times with a 7.3 weekly interval (44.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1744.95
first_seen: 2024-04-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-08
last_seen_parent: 2025-12-30
average_administered: [3.769230769230769, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 3.8 times with a 10.7 weekly interval (41.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1558.14
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [4.6069182389937104, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.6 times with a 8.6 weekly interval (39.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY
labels: RITUXIMAB
cost_pp_pa: 5994.25
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-31
average_administered: [11.118143459915611, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11.1 times with a 2.4 weekly interval (27.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3473.53
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-31
average_administered: [6.015384615384615, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 6.0 times with a 8.6 weekly interval (51.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 4126.49
first_seen: 2024-11-18T00:00:00
last_seen: 2025-11-20T00:00:00
first_seen_parent: 2024-11-18
last_seen_parent: 2025-11-20
average_administered: [3.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 3.0 times with a 13.7 weekly interval (41.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1887.29
first_seen: 2024-02-08T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-08
last_seen_parent: 2025-12-31
average_administered: [5.1, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.1 times with a 10.1 weekly interval (52.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4383.38
first_seen: 2024-06-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-06-04
last_seen_parent: 2025-12-31
average_administered: [6.4125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6.4 times with a 11.9 weekly interval (76.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 4234.9
first_seen: 2024-04-16T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-16
last_seen_parent: 2025-12-29
average_administered: [4.894736842105263, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4.9 times with a 7.1 weekly interval (35.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 5546.84
first_seen: 2024-04-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-29
average_administered: [5.1875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.2 times with a 6.9 weekly interval (36.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 7569.66
first_seen: 2025-01-25T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-12-02
last_seen_parent: 2025-12-30
average_administered: [2.357142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 2.4 times with a 4.0 weekly interval (10.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 829.78
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-30
average_administered: [4.396551724137931, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4.4 times with a 6.7 weekly interval (30.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 5419.58
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-31
average_administered: [1.962962962962963, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 2.0 times with a 14.4 weekly interval (29.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4733.92
first_seen: 2024-04-21T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-21
last_seen_parent: 2025-12-30
average_administered: [5.088888888888889, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.1 times with a 6.3 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3658.38
first_seen: 2024-02-21T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-02-21
last_seen_parent: 2025-11-26
average_administered: [8.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8.4 times with a 8.3 weekly interval (70.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 21289.62
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-30
average_administered: [10.661290322580646, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 10.7 times with a 3.4 weekly interval (37.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 3601.23
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-29
average_administered: [14.555555555555555, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 14.6 times with a 2.4 weekly interval (35.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 4223.71
first_seen: 2024-05-01T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-05-01
last_seen_parent: 2025-11-26
average_administered: [12.666666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL IMMUNOLOGY
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 12.7 times with a 2.9 weekly interval (36.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: TOCILIZUMAB
cost_pp_pa: 3376.61
first_seen: 2019-04-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-15
last_seen_parent: 2025-12-30
average_administered: [8.5, 2.75, 16.0, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|RITUXIMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - RITUXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - RITUXIMAB - TOCILIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.5 times with a 10.3 weekly interval (87.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 2.8 times with a 6.3 weekly interval (18.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 16.0 times with a 5.4 weekly interval (87.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: UPADACITINIB
cost_pp_pa: 4586.68
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [7.75, 7.125, 6.5, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB|USTEKINUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB - USTEKINUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB - USTEKINUMAB - UPADACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.8 times with a 6.4 weekly interval (50.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 7.1 times with a 22.3 weekly interval (158.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 6.5 times with a 31.4 weekly interval (204.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 4016.15
first_seen: 2019-06-28T00:00:00
last_seen: 2025-12-02T00:00:00
first_seen_parent: 2019-06-28
last_seen_parent: 2025-12-02
average_administered: [16.4, 1.6, 10.6, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|DEXAMETHASONE|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT - DEXAMETHASONE

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT - DEXAMETHASONE - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 16.4 times with a 12.4 weekly interval (204.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 1.6 times with a 4.9 weekly interval (8.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 10.6 times with a 5.7 weekly interval (61.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 2596.58
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-30
average_administered: [15.833333333333334, 6.833333333333333, 4.5, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT - RANIBIZUMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 15.8 times with a 11.7 weekly interval (185.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 6.8 times with a 6.0 weekly interval (41.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 4.5 times with a 17.4 weekly interval (78.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer
labels: BEVACIZUMAB
cost_pp_pa: 324.94
first_seen: 2023-04-13T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2023-04-13
last_seen_parent: 2025-12-31
average_administered: [4.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: non-small-cell lung cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4.2 times with a 7.6 weekly interval (32.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT - DEXAMETHASONE
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT - DEXAMETHASONE - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3194.47
first_seen: 2019-04-21T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-21
last_seen_parent: 2025-12-31
average_administered: [23.77777777777778, 2.3333333333333335, 6.444444444444445, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: AFLIBERCEPT|DEXAMETHASONE|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 23.8 times with a 12.6 weekly interval (299.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 2.3 times with a 22.1 weekly interval (51.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 6.4 times with a 4.0 weekly interval (26.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: RANIBIZUMAB
cost_pp_pa: 3852.21
first_seen: 2019-07-04T00:00:00
last_seen: 2025-12-20T00:00:00
first_seen_parent: 2019-07-04
last_seen_parent: 2025-12-20
average_administered: [24.0, 16.0, 1.4285714285714286, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT|FARICIMAB|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT - FARICIMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT - FARICIMAB - RANIBIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 24.0 times with a 7.0 weekly interval (168.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 16.0 times with a 9.6 weekly interval (153.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 1.4 times with a 3.9 weekly interval (5.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 3736.51
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-31
average_administered: [16.333333333333332, 10.733333333333333, 11.866666666666667, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - AFLIBERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 16.3 times with a 15.7 weekly interval (256.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 10.7 times with a 14.3 weekly interval (153.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 11.9 times with a 9.4 weekly interval (112.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer
labels: BEVACIZUMAB
cost_pp_pa: 283.02
first_seen: 2019-06-13T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-13
last_seen_parent: 2025-12-30
average_administered: [20.113636363636363, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: non-small-cell lung cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20.1 times with a 16.0 weekly interval (322.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 5009.01
first_seen: 2019-06-14T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2019-06-14
last_seen_parent: 2025-12-21
average_administered: [18.875, 12.875, 20.75, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - AFLIBERCEPT

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 18.9 times with a 8.1 weekly interval (154.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 12.9 times with a 9.9 weekly interval (127.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 20.8 times with a 4.4 weekly interval (92.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1763.83
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-18
average_administered: [12.428571428571429, 7.714285714285714, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 12.4 times with a 6.7 weekly interval (83.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 7.7 times with a 12.4 weekly interval (96.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 1926.59
first_seen: 2023-03-28T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2023-03-28
last_seen_parent: 2025-12-19
average_administered: [6.4, 2.2, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.4 times with a 10.6 weekly interval (68.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 2.2 times with a 10.3 weekly interval (23.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: USTEKINUMAB
cost_pp_pa: N/A
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB - USTEKINUMAB


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 6872.77
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-18
average_administered: [11.75, 17.5, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 11.8 times with a 4.0 weekly interval (47.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 17.5 times with a 8.0 weekly interval (140.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 10828.04
first_seen: 2022-11-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2022-10-20
last_seen_parent: 2025-12-31
average_administered: [7.333333333333333, 13.666666666666666, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7.3 times with a 3.4 weekly interval (25.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 13.7 times with a 4.9 weekly interval (67.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: UPADACITINIB
cost_pp_pa: 5981.81
first_seen: 2019-04-15T00:00:00
last_seen: 2025-12-05T00:00:00
first_seen_parent: 2019-04-15
last_seen_parent: 2025-12-05
average_administered: [4.8, 6.4, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: USTEKINUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - USTEKINUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - USTEKINUMAB - UPADACITINIB

average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 4.8 times with a 2.0 weekly interval (10.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 6.4 times with a 20.7 weekly interval (133.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: TOFACITINIB
cost_pp_pa: 5053.04
first_seen: 2019-04-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-07
last_seen_parent: 2025-12-30
average_administered: [8.307692307692308, 26.692307692307693, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB - TOFACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.3 times with a 7.6 weekly interval (63.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 26.7 times with a 8.3 weekly interval (221.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: UPADACITINIB
cost_pp_pa: 4145.14
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-22
average_administered: [9.6, 9.72, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB - UPADACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.6 times with a 6.7 weekly interval (64.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 9.7 times with a 8.1 weekly interval (79.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 2971.99
first_seen: 2019-04-09T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-09
last_seen_parent: 2025-12-29
average_administered: [21.085106382978722, 6.382978723404255, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21.1 times with a 8.9 weekly interval (187.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 6.4 times with a 5.0 weekly interval (32.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY (no GP dx) - BOTULINUM A TOXIN
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY (no GP dx) - BOTULINUM A TOXIN - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 1859.52
first_seen: 2019-04-25T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2019-04-25
last_seen_parent: 2025-12-17
average_administered: [3.5, 30.333333333333332, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY (no GP dx)
drug_sequence: BOTULINUM A TOXIN|FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BOTULINUM A TOXIN</b><br>On average given 3.5 times with a 10.7 weekly interval (38.0 weeks total treatment length)<br><b>FREMANEZUMAB</b><br>On average given 30.3 times with a 7.0 weekly interval (212.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: TOFACITINIB
cost_pp_pa: 4483.1
first_seen: 2019-05-06T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-05-06
last_seen_parent: 2025-12-23
average_administered: [10.0, 25.4, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB - TOFACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.0 times with a 7.4 weekly interval (74.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 25.4 times with a 8.1 weekly interval (207.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB
labels: USTEKINUMAB
cost_pp_pa: 5702.78
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [13.31578947368421, 15.578947368421053, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB - USTEKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13.3 times with a 10.4 weekly interval (139.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 15.6 times with a 9.7 weekly interval (152.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: ADALIMUMAB
cost_pp_pa: 4528.7
first_seen: 2019-04-11T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-23
average_administered: [27.333333333333332, 6.666666666666667, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB - ADALIMUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 27.3 times with a 3.6 weekly interval (98.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 6.7 times with a 9.6 weekly interval (64.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: INFLIXIMAB
cost_pp_pa: 3636.27
first_seen: 2019-05-06T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2019-04-24
last_seen_parent: 2025-12-16
average_administered: [24.6, 9.8, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB - INFLIXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 24.6 times with a 8.9 weekly interval (218.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 9.8 times with a 7.1 weekly interval (70.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4336.27
first_seen: 2023-09-13T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2023-09-13
last_seen_parent: 2025-12-24
average_administered: [7.0, 4.833333333333333, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 7.0 times with a 7.7 weekly interval (54.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 4.8 times with a 9.0 weekly interval (43.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB
labels: RITUXIMAB
cost_pp_pa: 1124.03
first_seen: 2019-06-07T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-12-18
average_administered: [8.1, 6.3, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - RITUXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.1 times with a 9.1 weekly interval (74.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 6.3 times with a 15.7 weekly interval (99.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - APREMILAST
labels: ADALIMUMAB
cost_pp_pa: 4611.66
first_seen: 2019-12-05T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-11-19
last_seen_parent: 2025-12-23
average_administered: [11.5, 10.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: APREMILAST|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - APREMILAST - ADALIMUMAB

average_spacing:
<br><b>APREMILAST</b><br>On average given 11.5 times with a 7.6 weekly interval (87.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 10.0 times with a 12.4 weekly interval (124.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 4467.84
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [17.2, 11.2, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17.2 times with a 16.1 weekly interval (278.0 weeks total treatment length)<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 11.2 times with a 12.6 weekly interval (141.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 3189.1
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [6.517241379310345, 18.551724137931036, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6.5 times with a 46.9 weekly interval (305.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 18.6 times with a 4.3 weekly interval (80.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: ETANERCEPT
cost_pp_pa: 3511.36
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-23
average_administered: [14.75, 15.1875, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ADALIMUMAB - ETANERCEPT

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.8 times with a 7.9 weekly interval (116.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 15.2 times with a 6.1 weekly interval (93.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: AFLIBERCEPT
cost_pp_pa: 3266.14
first_seen: 2019-04-28T00:00:00
last_seen: 2025-11-14T00:00:00
first_seen_parent: 2019-04-28
last_seen_parent: 2025-11-14
average_administered: [21.666666666666668, 14.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 21.7 times with a 7.1 weekly interval (155.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 14.0 times with a 30.7 weekly interval (430.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1649.03
first_seen: 2021-02-04T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2021-02-04
last_seen_parent: 2025-12-22
average_administered: [6.0, 4.142857142857143, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.0 times with a 7.0 weekly interval (42.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 4.1 times with a 8.7 weekly interval (36.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 5309.57
first_seen: 2019-07-01T00:00:00
last_seen: 2025-12-10T00:00:00
first_seen_parent: 2019-07-01
last_seen_parent: 2025-12-29
average_administered: [11.4, 27.4, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.4 times with a 5.6 weekly interval (64.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 27.4 times with a 6.1 weekly interval (168.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB - UPADACITINIB
labels: UPADACITINIB
cost_pp_pa: 3213.48
first_seen: 2023-12-20T00:00:00
last_seen: 2025-12-10T00:00:00
first_seen_parent: 2023-12-20
last_seen_parent: 2025-12-10
average_administered: [2.5, 1.75, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.5 times with a 5.9 weekly interval (15.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 1.8 times with a 7.7 weekly interval (14.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - ADALIMUMAB - IXEKIZUMAB
labels: IXEKIZUMAB
cost_pp_pa: 5916.39
first_seen: 2020-12-01T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2020-12-01
last_seen_parent: 2025-12-31
average_administered: [10.333333333333334, 8.333333333333334, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: plaque psoriasis
drug_sequence: ADALIMUMAB|IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.3 times with a 6.6 weekly interval (68.0 weeks total treatment length)<br><b>IXEKIZUMAB</b><br>On average given 8.3 times with a 8.9 weekly interval (74.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - ADALIMUMAB - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 6359.62
first_seen: 2020-09-29T00:00:00
last_seen: 2025-12-10T00:00:00
first_seen_parent: 2020-09-29
last_seen_parent: 2025-12-10
average_administered: [10.0, 5.25, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: plaque psoriasis
drug_sequence: ADALIMUMAB|RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.0 times with a 5.0 weekly interval (50.0 weeks total treatment length)<br><b>RISANKIZUMAB</b><br>On average given 5.2 times with a 10.7 weekly interval (56.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB
labels: SECUKINUMAB
cost_pp_pa: 4682.29
first_seen: 2021-03-16T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2019-07-02
last_seen_parent: 2025-09-26
average_administered: [7.25, 7.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.2 times with a 7.9 weekly interval (57.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 7.0 times with a 16.3 weekly interval (114.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB
labels: USTEKINUMAB
cost_pp_pa: 2661.25
first_seen: 2019-06-27T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-06-27
last_seen_parent: 2025-12-18
average_administered: [6.5, 3.8333333333333335, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB - USTEKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.5 times with a 12.7 weekly interval (83.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 3.8 times with a 13.7 weekly interval (52.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: RITUXIMAB
cost_pp_pa: 3481.84
first_seen: 2019-05-10T00:00:00
last_seen: 2025-11-06T00:00:00
first_seen_parent: 2019-05-10
last_seen_parent: 2025-12-24
average_administered: [24.666666666666668, 7.333333333333333, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ADALIMUMAB - RITUXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 24.7 times with a 7.3 weekly interval (180.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 7.3 times with a 14.1 weekly interval (103.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: SECUKINUMAB
cost_pp_pa: 6050.76
first_seen: 2019-04-24T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2019-04-19
last_seen_parent: 2025-12-22
average_administered: [6.25, 31.5, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.2 times with a 5.9 weekly interval (36.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 31.5 times with a 9.3 weekly interval (292.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - migraine - BOTULINUM A TOXIN
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - migraine - BOTULINUM A TOXIN - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 1880.28
first_seen: 2019-05-09T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-05-09
last_seen_parent: 2025-12-29
average_administered: [3.2857142857142856, 30.857142857142858, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: migraine
drug_sequence: BOTULINUM A TOXIN|FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BOTULINUM A TOXIN</b><br>On average given 3.3 times with a 9.6 weekly interval (32.0 weeks total treatment length)<br><b>FREMANEZUMAB</b><br>On average given 30.9 times with a 7.4 weekly interval (230.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: RANIBIZUMAB
cost_pp_pa: 2160.13
first_seen: 2019-06-25T00:00:00
last_seen: 2025-12-27T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-27
average_administered: [13.88888888888889, 4.777777777777778, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT - RANIBIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 13.9 times with a 10.0 weekly interval (139.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 4.8 times with a 8.4 weekly interval (40.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: 5435.25
first_seen: 2019-06-25T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2019-06-14
last_seen_parent: 2025-12-21
average_administered: [9.333333333333334, 13.11111111111111, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9.3 times with a 9.7 weekly interval (90.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 13.1 times with a 11.7 weekly interval (153.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 3918.11
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-04
last_seen_parent: 2025-12-30
average_administered: [10.857142857142858, 16.485714285714284, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 10.9 times with a 16.3 weekly interval (178.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 16.5 times with a 9.0 weekly interval (148.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: FARICIMAB
cost_pp_pa: 4257.68
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [20.52577319587629, 12.855670103092784, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20.5 times with a 7.6 weekly interval (155.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 12.9 times with a 7.6 weekly interval (98.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: 5923.5
first_seen: 2021-01-28T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2019-06-22
last_seen_parent: 2025-12-21
average_administered: [6.5, 11.5, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6.5 times with a 10.1 weekly interval (66.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 11.5 times with a 6.3 weekly interval (72.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: DEXAMETHASONE
cost_pp_pa: 6013.12
first_seen: 2023-03-26T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2019-06-28
last_seen_parent: 2025-12-21
average_administered: [2.0, 6.5, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB - DEXAMETHASONE

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.0 times with a 13.0 weekly interval (26.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 6.5 times with a 26.0 weekly interval (169.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3862.78
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [7.568627450980392, 10.568627450980392, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 7.6 times with a 14.0 weekly interval (106.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 10.6 times with a 13.6 weekly interval (144.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - RANIBIZUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - RANIBIZUMAB - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 1465.63
first_seen: 2019-04-08T00:00:00
last_seen: 2025-11-24T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-11-24
average_administered: [6.4, 12.2, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6.4 times with a 35.3 weekly interval (226.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 12.2 times with a 5.0 weekly interval (61.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - INFLIXIMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - INFLIXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 9880.56
first_seen: 2020-05-27T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2020-05-27
last_seen_parent: 2025-12-17
average_administered: [7.0, 15.333333333333334, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7.0 times with a 5.9 weekly interval (41.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 15.3 times with a 5.7 weekly interval (87.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: ADALIMUMAB
cost_pp_pa: 2610.93
first_seen: 2019-04-15T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-15
last_seen_parent: 2025-12-30
average_administered: [21.285714285714285, 15.357142857142858, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ETANERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ETANERCEPT - ADALIMUMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 21.3 times with a 12.9 weekly interval (274.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 15.4 times with a 51.7 weekly interval (796.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 3606.1
first_seen: 2019-05-08T00:00:00
last_seen: 2025-10-15T00:00:00
first_seen_parent: 2019-04-21
last_seen_parent: 2025-12-31
average_administered: [27.5, 4.75, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: AFLIBERCEPT|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 27.5 times with a 11.1 weekly interval (306.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 4.8 times with a 15.1 weekly interval (73.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 2823.87
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [20.09090909090909, 6.090909090909091, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20.1 times with a 9.6 weekly interval (192.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 6.1 times with a 5.0 weekly interval (30.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - RANIBIZUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - RANIBIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 1783.94
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-15
average_administered: [5.571428571428571, 14.0, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 5.6 times with a 33.4 weekly interval (187.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 14.0 times with a 5.4 weekly interval (76.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 3149.77
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [8.098360655737705, 15.081967213114755, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 8.1 times with a 34.6 weekly interval (280.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 15.1 times with a 6.7 weekly interval (101.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: VEDOLIZUMAB
cost_pp_pa: 7105.43
first_seen: 2019-04-25T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-25
last_seen_parent: 2025-12-30
average_administered: [7.3076923076923075, 16.923076923076923, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB - VEDOLIZUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7.3 times with a 5.4 weekly interval (40.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 16.9 times with a 7.6 weekly interval (128.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ADALIMUMAB - IXEKIZUMAB
labels: IXEKIZUMAB
cost_pp_pa: 6006.84
first_seen: 2021-05-24T00:00:00
last_seen: 2025-12-10T00:00:00
first_seen_parent: 2021-05-24
last_seen_parent: 2025-12-10
average_administered: [7.0, 7.142857142857143, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB|IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.0 times with a 7.9 weekly interval (55.0 weeks total treatment length)<br><b>IXEKIZUMAB</b><br>On average given 7.1 times with a 10.3 weekly interval (73.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ADALIMUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 3917.51
first_seen: 2020-11-30T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2020-11-30
last_seen_parent: 2025-12-29
average_administered: [9.166666666666666, 14.166666666666666, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.2 times with a 7.7 weekly interval (71.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 14.2 times with a 7.3 weekly interval (103.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: FARICIMAB
cost_pp_pa: 3145.22
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-30
average_administered: [12.46774193548387, 8.161290322580646, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 12.5 times with a 12.4 weekly interval (155.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 8.2 times with a 7.3 weekly interval (60.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: SECUKINUMAB
cost_pp_pa: 4296.33
first_seen: 2019-04-19T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-19
last_seen_parent: 2025-12-30
average_administered: [6.2, 15.6, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.2 times with a 5.9 weekly interval (36.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 15.6 times with a 7.0 weekly interval (109.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: 4388.01
first_seen: 2019-04-22T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-04
average_administered: [15.625, 16.1875, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 15.6 times with a 7.6 weekly interval (118.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 16.2 times with a 12.0 weekly interval (194.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - AFLIBERCEPT - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 2884.68
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-23
average_administered: [24.169811320754718, 5.471698113207547, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 24.2 times with a 9.7 weekly interval (235.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 5.5 times with a 4.9 weekly interval (27.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: DEXAMETHASONE
cost_pp_pa: 3684.07
first_seen: 2019-10-06T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2019-06-28
last_seen_parent: 2025-12-30
average_administered: [15.0, 5.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT - DEXAMETHASONE

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 15.0 times with a 7.9 weekly interval (118.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 5.0 times with a 26.3 weekly interval (131.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3941.97
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-21
average_administered: [20.75862068965517, 11.931034482758621, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20.8 times with a 7.9 weekly interval (163.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 11.9 times with a 7.7 weekly interval (92.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: RANIBIZUMAB
cost_pp_pa: 2429.11
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [13.0, 9.25, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT - RANIBIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 13.0 times with a 12.1 weekly interval (158.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 9.2 times with a 8.6 weekly interval (79.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: VEDOLIZUMAB
cost_pp_pa: 6849.13
first_seen: 2020-05-01T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2020-05-01
last_seen_parent: 2025-12-31
average_administered: [11.4, 10.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB - VEDOLIZUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 11.4 times with a 7.7 weekly interval (88.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 10.0 times with a 4.9 weekly interval (49.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 3155.06
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-24
average_administered: [19.733333333333334, 9.333333333333334, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 19.7 times with a 10.1 weekly interval (200.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 9.3 times with a 7.4 weekly interval (69.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: RANIBIZUMAB
cost_pp_pa: 3032.28
first_seen: 2019-05-04T00:00:00
last_seen: 2025-11-21T00:00:00
first_seen_parent: 2019-05-04
last_seen_parent: 2025-11-21
average_administered: [26.166666666666668, 4.666666666666667, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT - RANIBIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 26.2 times with a 11.4 weekly interval (299.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 4.7 times with a 4.6 weekly interval (21.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2281.39
first_seen: 2019-04-18T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-18
last_seen_parent: 2025-12-22
average_administered: [12.666666666666666, 13.166666666666666, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 12.7 times with a 14.9 weekly interval (189.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 13.2 times with a 33.3 weekly interval (439.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 2244.89
first_seen: 2019-04-18T00:00:00
last_seen: 2025-12-12T00:00:00
first_seen_parent: 2019-04-18
last_seen_parent: 2025-12-12
average_administered: [5.166666666666667, 23.666666666666668, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 5.2 times with a 77.7 weekly interval (404.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 23.7 times with a 2.3 weekly interval (54.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: AFLIBERCEPT
cost_pp_pa: 3533.81
first_seen: 2019-04-02T00:00:00
last_seen: 2025-11-21T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [17.953488372093023, 17.046511627906977, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 18.0 times with a 14.3 weekly interval (257.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 17.0 times with a 14.3 weekly interval (243.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 3097.29
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-31
average_administered: [8.28780487804878, 15.53170731707317, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 8.3 times with a 28.9 weekly interval (240.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 15.5 times with a 5.7 weekly interval (89.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: INFLIXIMAB
cost_pp_pa: 3031.01
first_seen: 2019-04-19T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2019-04-09
last_seen_parent: 2025-12-30
average_administered: [8.833333333333334, 16.666666666666668, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB - INFLIXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.8 times with a 6.3 weekly interval (55.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 16.7 times with a 7.9 weekly interval (131.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: IXEKIZUMAB
cost_pp_pa: 4594.65
first_seen: 2019-04-23T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-18
average_administered: [9.88888888888889, 12.222222222222221, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB|IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB - IXEKIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.9 times with a 9.1 weekly interval (91.0 weeks total treatment length)<br><b>IXEKIZUMAB</b><br>On average given 12.2 times with a 8.1 weekly interval (99.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: SECUKINUMAB
cost_pp_pa: 5458.67
first_seen: 2019-04-09T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-29
average_administered: [7.2727272727272725, 19.636363636363637, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.3 times with a 7.3 weekly interval (53.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 19.6 times with a 10.0 weekly interval (196.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: ADALIMUMAB
cost_pp_pa: 3648.5
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2019-05-13
last_seen_parent: 2025-12-22
average_administered: [19.666666666666668, 7.333333333333333, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: APREMILAST|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - APREMILAST

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - APREMILAST - ADALIMUMAB

average_spacing:
<br><b>APREMILAST</b><br>On average given 19.7 times with a 5.0 weekly interval (98.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 7.3 times with a 71.9 weekly interval (525.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: ABATACEPT
cost_pp_pa: 4728.06
first_seen: 2019-11-25T00:00:00
last_seen: 2025-12-05T00:00:00
first_seen_parent: 2019-05-20
last_seen_parent: 2025-12-18
average_administered: [20.5, 8.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|ABATACEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - ABATACEPT

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 20.5 times with a 3.6 weekly interval (73.0 weeks total treatment length)<br><b>ABATACEPT</b><br>On average given 8.0 times with a 8.3 weekly interval (66.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: USTEKINUMAB
cost_pp_pa: N/A
first_seen_parent: 2019-04-09
last_seen_parent: 2025-12-23
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB - USTEKINUMAB


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 2475.53
first_seen: 2019-05-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-05-03
last_seen_parent: 2025-12-29
average_administered: [16.5, 2.5, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 16.5 times with a 11.3 weekly interval (186.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 2.5 times with a 21.1 weekly interval (53.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 4182.8
first_seen: 2019-07-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-07-10
last_seen_parent: 2025-12-30
average_administered: [8.5, 14.166666666666666, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 8.5 times with a 17.1 weekly interval (146.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 14.2 times with a 11.3 weekly interval (160.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: BARICITINIB
cost_pp_pa: 3557.32
first_seen: 2020-09-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2020-09-04
last_seen_parent: 2025-12-30
average_administered: [3.25, 13.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - BARICITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.2 times with a 9.1 weekly interval (29.0 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 13.0 times with a 12.9 weekly interval (167.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 4184.72
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-05T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-31
average_administered: [18.0, 13.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18.0 times with a 9.4 weekly interval (170.0 weeks total treatment length)<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 13.0 times with a 4.4 weekly interval (58.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: FILGOTINIB
cost_pp_pa: 2422.42
first_seen: 2021-09-02T00:00:00
last_seen: 2025-12-12T00:00:00
first_seen_parent: 2020-12-01
last_seen_parent: 2025-12-12
average_administered: [8.4, 11.4, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - FILGOTINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.4 times with a 7.0 weekly interval (59.0 weeks total treatment length)<br><b>FILGOTINIB</b><br>On average given 11.4 times with a 5.0 weekly interval (57.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: RITUXIMAB
cost_pp_pa: 2556.24
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-05T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [8.095238095238095, 6.571428571428571, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - RITUXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.1 times with a 7.4 weekly interval (60.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 6.6 times with a 18.0 weekly interval (119.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: UPADACITINIB
cost_pp_pa: 2235.49
first_seen: 2019-04-23T00:00:00
last_seen: 2025-11-24T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-11-24
average_administered: [16.4, 10.6, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - UPADACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16.4 times with a 6.6 weekly interval (108.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 10.6 times with a 6.4 weekly interval (68.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - ADALIMUMAB - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 6674.07
first_seen: 2019-04-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-28
last_seen_parent: 2025-12-31
average_administered: [6.0, 8.285714285714286, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB|RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.0 times with a 7.9 weekly interval (47.0 weeks total treatment length)<br><b>RISANKIZUMAB</b><br>On average given 8.3 times with a 13.4 weekly interval (111.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: ABATACEPT
cost_pp_pa: 4160.83
first_seen: 2019-04-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-31
average_administered: [23.90909090909091, 4.7272727272727275, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB|ABATACEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB - ABATACEPT

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 23.9 times with a 16.6 weekly interval (396.0 weeks total treatment length)<br><b>ABATACEPT</b><br>On average given 4.7 times with a 45.4 weekly interval (214.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 4498.33
first_seen: 2020-05-29T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2020-05-29
last_seen_parent: 2025-12-31
average_administered: [12.857142857142858, 7.142857142857143, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ulcerative colitis
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12.9 times with a 8.9 weekly interval (114.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 7.1 times with a 8.7 weekly interval (62.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: USTEKINUMAB
cost_pp_pa: 7205.91
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-29
average_administered: [5.833333333333333, 22.166666666666668, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB - USTEKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.8 times with a 5.6 weekly interval (32.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 22.2 times with a 11.6 weekly interval (257.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - USTEKINUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - USTEKINUMAB - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 8945.29
first_seen: 2019-04-18T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-18
last_seen_parent: 2025-12-23
average_administered: [12.8, 11.2, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: USTEKINUMAB|RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 12.8 times with a 49.9 weekly interval (638.0 weeks total treatment length)<br><b>RISANKIZUMAB</b><br>On average given 11.2 times with a 42.0 weekly interval (470.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY (no GP dx)
labels: OMALIZUMAB
cost_pp_pa: 3638.43
first_seen: 2021-04-14T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2021-04-14
last_seen_parent: 2025-11-26
average_administered: [21.142857142857142, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL IMMUNOLOGY (no GP dx)
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY (no GP dx) - OMALIZUMAB

average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 21.1 times with a 3.6 weekly interval (75.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 5847.54
first_seen: 2022-09-08T00:00:00
last_seen: 2025-11-13T00:00:00
first_seen_parent: 2019-06-28
last_seen_parent: 2025-11-13
average_administered: [6.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.3 times with a 7.0 weekly interval (44.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx)
labels: ACALABRUTINIB
cost_pp_pa: 23431.55
first_seen: 2021-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-04-02
last_seen_parent: 2025-12-30
average_administered: [8.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 8.4 times with a 14.9 weekly interval (125.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx)
labels: RITUXIMAB
cost_pp_pa: 2935.86
first_seen: 2024-09-24T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-09-24
last_seen_parent: 2025-12-24
average_administered: [8.375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 8.4 times with a 1.6 weekly interval (13.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1748.18
first_seen: 2019-06-21T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2019-06-21
last_seen_parent: 2025-11-25
average_administered: [15.333333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15.3 times with a 7.0 weekly interval (107.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3152.74
first_seen: 2019-06-05T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-11-27
average_administered: [16.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16.0 times with a 7.9 weekly interval (126.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2643.53
first_seen: 2020-10-14T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-28
last_seen_parent: 2025-12-31
average_administered: [11.229166666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.2 times with a 8.9 weekly interval (99.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - APREMILAST
labels: APREMILAST
cost_pp_pa: 4349.67
first_seen: 2019-05-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-05-01
last_seen_parent: 2025-12-31
average_administered: [22.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>APREMILAST</b><br>On average given 22.8 times with a 11.7 weekly interval (267.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3637.38
first_seen: 2019-04-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-10
last_seen_parent: 2025-12-30
average_administered: [28.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 28.6 times with a 14.6 weekly interval (417.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 8769.85
first_seen: 2019-07-01T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-07-01
last_seen_parent: 2025-12-29
average_administered: [15.666666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RISANKIZUMAB</b><br>On average given 15.7 times with a 12.6 weekly interval (197.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - BREAST SURGERY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - BREAST SURGERY (no GP dx) - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1439.23
first_seen: 2025-05-30T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-05-30
last_seen_parent: 2025-12-31
average_administered: [3.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: BREAST SURGERY (no GP dx)
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 3.4 times with a 2.7 weekly interval (9.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx) - ACALABRUTINIB
labels: ACALABRUTINIB
cost_pp_pa: 31436.55
first_seen: 2024-05-01T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-05-01
last_seen_parent: 2025-12-19
average_administered: [13.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 13.0 times with a 4.9 weekly interval (63.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx) - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2897.68
first_seen: 2024-04-17T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-17
last_seen_parent: 2025-12-31
average_administered: [8.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 8.2 times with a 4.0 weekly interval (33.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx) - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 35287.3
first_seen: 2025-08-22T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2025-08-22
last_seen_parent: 2025-11-27
average_administered: [3.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 3.0 times with a 0.9 weekly interval (3.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: ABATACEPT
cost_pp_pa: 261772.14
first_seen: 2025-12-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [2.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ABATACEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ABATACEPT

average_spacing:
<br><b>ABATACEPT</b><br>On average given 2.0 times with a 3.1 weekly interval (6.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: ADALIMUMAB
cost_pp_pa: 1777.23
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [25.726377952755904, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25.7 times with a 8.4 weekly interval (217.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: BARICITINIB
cost_pp_pa: 4865.98
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [21.38888888888889, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - BARICITINIB

average_spacing:
<br><b>BARICITINIB</b><br>On average given 21.4 times with a 12.9 weekly interval (275.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 8680.46
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-29
average_administered: [20.333333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 20.3 times with a 10.3 weekly interval (209.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: FILGOTINIB
cost_pp_pa: 2626.51
first_seen: 2022-11-09T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2022-11-09
last_seen_parent: 2025-12-30
average_administered: [9.11111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - FILGOTINIB

average_spacing:
<br><b>FILGOTINIB</b><br>On average given 9.1 times with a 6.9 weekly interval (62.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: GOLIMUMAB
cost_pp_pa: 8079.62
first_seen: 2019-04-15T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-18
average_administered: [34.333333333333336, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: GOLIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - GOLIMUMAB

average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 34.3 times with a 8.6 weekly interval (294.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: RITUXIMAB
cost_pp_pa: 2118.5
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [9.371428571428572, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9.4 times with a 25.9 weekly interval (243.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: TOCILIZUMAB
cost_pp_pa: 7411.09
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-29
average_administered: [79.46153846153847, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - TOCILIZUMAB

average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 79.5 times with a 5.1 weekly interval (409.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1734.95
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [33.58139534883721, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: uveitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 33.6 times with a 8.1 weekly interval (274.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - TILDRAKIZUMAB
labels: TILDRAKIZUMAB
cost_pp_pa: 7710.13
first_seen: 2021-04-15T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2021-04-15
last_seen_parent: 2025-12-31
average_administered: [16.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: TILDRAKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TILDRAKIZUMAB</b><br>On average given 16.0 times with a 12.4 weekly interval (199.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - UPADACITINIB
labels: UPADACITINIB
cost_pp_pa: 7170.4
first_seen: 2023-01-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2023-01-03
last_seen_parent: 2025-12-31
average_administered: [7.7894736842105265, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>UPADACITINIB</b><br>On average given 7.8 times with a 9.0 weekly interval (70.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8016.98
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-29
average_administered: [24.35483870967742, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 24.4 times with a 12.7 weekly interval (310.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
labels: ADALIMUMAB
cost_pp_pa: 2233.68
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [27.967509025270758, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28.0 times with a 8.3 weekly interval (232.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
labels: TOFACITINIB
cost_pp_pa: 5471.66
first_seen: 2019-11-15T00:00:00
last_seen: 2025-12-05T00:00:00
first_seen_parent: 2019-11-15
last_seen_parent: 2025-12-05
average_administered: [25.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: TOFACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - TOFACITINIB

average_spacing:
<br><b>TOFACITINIB</b><br>On average given 25.0 times with a 7.3 weekly interval (182.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
labels: UPADACITINIB
cost_pp_pa: 8253.55
first_seen: 2023-09-15T00:00:00
last_seen: 2025-12-12T00:00:00
first_seen_parent: 2023-09-15
last_seen_parent: 2025-12-12
average_administered: [9.066666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - UPADACITINIB

average_spacing:
<br><b>UPADACITINIB</b><br>On average given 9.1 times with a 6.7 weekly interval (61.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: SECUKINUMAB
cost_pp_pa: 8143.72
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-29
average_administered: [21.083333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - SECUKINUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 21.1 times with a 9.4 weekly interval (199.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: EVOLOCUMAB
cost_pp_pa: 2026.42
first_seen: 2019-04-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-30
average_administered: [35.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: primary hypercholesterolaemia
drug_sequence: EVOLOCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - primary hypercholesterolaemia

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - primary hypercholesterolaemia - EVOLOCUMAB

average_spacing:
<br><b>EVOLOCUMAB</b><br>On average given 35.5 times with a 4.9 weekly interval (172.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
labels: ADALIMUMAB
cost_pp_pa: 1997.7
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [27.78205128205128, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27.8 times with a 9.6 weekly interval (266.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 9206.01
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [27.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 27.5 times with a 9.6 weekly interval (263.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
labels: ETANERCEPT
cost_pp_pa: 3464.01
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-29
average_administered: [32.54838709677419, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - ETANERCEPT

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 32.5 times with a 8.4 weekly interval (274.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
labels: GOLIMUMAB
cost_pp_pa: 7799.19
first_seen: 2019-04-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-07
last_seen_parent: 2025-12-30
average_administered: [29.833333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: GOLIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - GOLIMUMAB

average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 29.8 times with a 9.3 weekly interval (277.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1108.18
first_seen: 2021-05-18T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2021-05-18
last_seen_parent: 2025-12-29
average_administered: [9.727272727272727, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.7 times with a 10.7 weekly interval (104.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2790.4
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-31
average_administered: [16.715736040609137, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 16.7 times with a 11.7 weekly interval (196.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: APREMILAST
cost_pp_pa: 6042.71
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-22
average_administered: [14.38888888888889, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - APREMILAST

average_spacing:
<br><b>APREMILAST</b><br>On average given 14.4 times with a 10.7 weekly interval (154.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 9652.63
first_seen: 2019-04-19T00:00:00
last_seen: 2025-11-14T00:00:00
first_seen_parent: 2019-04-17
last_seen_parent: 2025-12-04
average_administered: [24.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 24.0 times with a 10.0 weekly interval (240.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: INFLIXIMAB
cost_pp_pa: 3552.26
first_seen: 2019-04-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-31
average_administered: [29.041666666666668, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 29.0 times with a 7.0 weekly interval (203.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: IXEKIZUMAB
cost_pp_pa: 8575.09
first_seen: 2020-03-09T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-22
average_administered: [23.666666666666668, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - IXEKIZUMAB

average_spacing:
<br><b>IXEKIZUMAB</b><br>On average given 23.7 times with a 9.0 weekly interval (213.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY (no GP dx) - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 2960.73
first_seen: 2025-05-07T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2024-04-15
last_seen_parent: 2025-12-18
average_administered: [4.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY (no GP dx)
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 4.3 times with a 2.6 weekly interval (11.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY (no GP dx) - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2342.18
first_seen: 2021-04-26T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-04-26
last_seen_parent: 2025-12-30
average_administered: [18.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY (no GP dx)
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 18.4 times with a 9.6 weekly interval (176.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY (no GP dx) - GALCANEZUMAB
labels: GALCANEZUMAB
cost_pp_pa: 2838.82
first_seen: 2022-07-09T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2022-07-09
last_seen_parent: 2025-12-31
average_administered: [16.142857142857142, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY (no GP dx)
drug_sequence: GALCANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GALCANEZUMAB</b><br>On average given 16.1 times with a 8.4 weekly interval (136.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: TOFACITINIB
cost_pp_pa: 3977.35
first_seen: 2019-04-15T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2019-04-15
last_seen_parent: 2025-12-11
average_administered: [26.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: TOFACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - TOFACITINIB

average_spacing:
<br><b>TOFACITINIB</b><br>On average given 26.0 times with a 7.0 weekly interval (182.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: UPADACITINIB
cost_pp_pa: 4415.34
first_seen: 2022-03-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2022-03-04
last_seen_parent: 2025-12-29
average_administered: [21.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - UPADACITINIB

average_spacing:
<br><b>UPADACITINIB</b><br>On average given 21.2 times with a 6.9 weekly interval (145.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2902.72
first_seen: 2019-04-17T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-17
last_seen_parent: 2025-12-31
average_administered: [10.94, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.9 times with a 10.1 weekly interval (111.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4210.75
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-31
average_administered: [27.526315789473685, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 27.5 times with a 6.4 weekly interval (177.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 21878.99
first_seen: 2024-09-13T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-09-13
last_seen_parent: 2025-12-31
average_administered: [5.285714285714286, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RISANKIZUMAB</b><br>On average given 5.3 times with a 4.6 weekly interval (24.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 9138.04
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-30
average_administered: [20.727272727272727, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 20.7 times with a 9.6 weekly interval (198.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 12735.95
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [22.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 22.0 times with a 6.6 weekly interval (145.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2294.89
first_seen: 2019-04-05T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-05
last_seen_parent: 2025-12-31
average_administered: [12.370860927152318, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12.4 times with a 9.9 weekly interval (122.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - BARICITINIB
labels: BARICITINIB
cost_pp_pa: 5309.14
first_seen: 2019-11-13T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-05-17
last_seen_parent: 2025-12-30
average_administered: [19.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BARICITINIB</b><br>On average given 19.5 times with a 11.7 weekly interval (228.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4710.91
first_seen: 2019-06-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-28
last_seen_parent: 2025-12-31
average_administered: [8.409090909090908, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 8.4 times with a 11.9 weekly interval (100.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - GOLIMUMAB
labels: GOLIMUMAB
cost_pp_pa: 8925.15
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [43.3, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: GOLIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 43.3 times with a 7.7 weekly interval (334.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3640.91
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-30
average_administered: [30.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 30.6 times with a 5.9 weekly interval (179.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: TOCILIZUMAB
cost_pp_pa: 5520.9
first_seen: 2019-04-30T00:00:00
last_seen: 2025-12-12T00:00:00
first_seen_parent: 2019-04-30
last_seen_parent: 2025-12-15
average_administered: [33.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: juvenile idiopathic arthritis
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - juvenile idiopathic arthritis

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - juvenile idiopathic arthritis - TOCILIZUMAB

average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 33.8 times with a 7.9 weekly interval (266.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
labels: AFLIBERCEPT
cost_pp_pa: 2380.16
first_seen: 2019-04-02T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-24
average_administered: [20.767441860465116, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20.8 times with a 16.6 weekly interval (345.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2748.94
first_seen: 2021-05-04T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2021-05-04
last_seen_parent: 2025-12-23
average_administered: [13.396039603960396, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: migraine
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 13.4 times with a 14.0 weekly interval (188.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - multiple sclerosis
labels: DIMETHYL FUMARATE
cost_pp_pa: 2244.51
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-30
average_administered: [7.257575757575758, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: multiple sclerosis
drug_sequence: DIMETHYL FUMARATE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - multiple sclerosis - DIMETHYL FUMARATE

average_spacing:
<br><b>DIMETHYL FUMARATE</b><br>On average given 7.3 times with a 11.6 weekly interval (84.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 5763.84
first_seen: 2019-05-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-18
last_seen_parent: 2025-12-31
average_administered: [6.208333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6.2 times with a 5.0 weekly interval (31.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3009.74
first_seen: 2019-04-22T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-30
average_administered: [11.11864406779661, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 11.1 times with a 13.7 weekly interval (152.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 3019.53
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [12.882022471910112, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 12.9 times with a 9.9 weekly interval (127.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma
labels: OBINUTUZUMAB
cost_pp_pa: 37528.32
first_seen: 2025-04-17T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-09-02
last_seen_parent: 2025-12-31
average_administered: [8.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: follicular lymphoma
drug_sequence: OBINUTUZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma - OBINUTUZUMAB

average_spacing:
<br><b>OBINUTUZUMAB</b><br>On average given 8.5 times with a 2.0 weekly interval (17.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma
labels: RITUXIMAB
cost_pp_pa: 5790.54
first_seen: 2024-04-08T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-08
last_seen_parent: 2025-12-31
average_administered: [12.053191489361701, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12.1 times with a 2.9 weekly interval (35.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - giant cell arteritis
labels: TOCILIZUMAB
cost_pp_pa: 11392.44
first_seen: 2022-12-12T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2022-12-12
last_seen_parent: 2025-12-29
average_administered: [9.214285714285714, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: giant cell arteritis
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - giant cell arteritis - TOCILIZUMAB

average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 9.2 times with a 4.1 weekly interval (38.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
labels: UPADACITINIB
cost_pp_pa: 4428.51
first_seen: 2022-11-09T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2022-11-09
last_seen_parent: 2025-12-18
average_administered: [12.375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - UPADACITINIB

average_spacing:
<br><b>UPADACITINIB</b><br>On average given 12.4 times with a 6.1 weekly interval (76.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion
labels: DEXAMETHASONE
cost_pp_pa: 2495.83
first_seen: 2023-02-13T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2023-02-13
last_seen_parent: 2025-12-31
average_administered: [3.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: retinal vein occlusion
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion - DEXAMETHASONE

average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 3.5 times with a 34.9 weekly interval (122.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: ADALIMUMAB
cost_pp_pa: 2159.17
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [25.991071428571427, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26.0 times with a 8.6 weekly interval (223.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 332.6
first_seen: 2021-03-16T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-03-16
last_seen_parent: 2025-12-30
average_administered: [3.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 3.5 times with a 23.1 weekly interval (81.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4116.39
first_seen: 2024-02-09T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-09
last_seen_parent: 2025-12-29
average_administered: [6.511111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 6.5 times with a 6.3 weekly interval (41.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - breast cancer
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - breast cancer - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1803.37
first_seen: 2025-07-02T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2025-07-02
last_seen_parent: 2025-12-19
average_administered: [3.3333333333333335, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: breast cancer
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 3.3 times with a 2.4 weekly interval (8.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - chronic lymphocytic leukaemia
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - chronic lymphocytic leukaemia - ACALABRUTINIB
labels: ACALABRUTINIB
cost_pp_pa: 29319.57
first_seen: 2024-05-01T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2024-05-01
last_seen_parent: 2025-12-16
average_administered: [14.625, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: chronic lymphocytic leukaemia
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 14.6 times with a 5.3 weekly interval (77.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - chronic lymphocytic leukaemia
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - chronic lymphocytic leukaemia - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 5497.36
first_seen: 2024-04-17T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-17
last_seen_parent: 2025-12-31
average_administered: [8.157894736842104, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 8.2 times with a 3.7 weekly interval (30.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer
labels: BEVACIZUMAB
cost_pp_pa: 622.38
first_seen: 2022-03-09T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2022-03-09
last_seen_parent: 2025-12-15
average_administered: [8.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: breast cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 8.6 times with a 18.3 weekly interval (157.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: ACALABRUTINIB
cost_pp_pa: 30123.94
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-29
average_administered: [18.097560975609756, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 18.1 times with a 4.4 weekly interval (80.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: RITUXIMAB
cost_pp_pa: 6015.73
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-31
average_administered: [9.62, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9.6 times with a 2.9 weekly interval (27.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
labels: INFLIXIMAB
cost_pp_pa: 3728.01
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [18.140243902439025, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 18.1 times with a 6.6 weekly interval (119.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
labels: VEDOLIZUMAB
cost_pp_pa: 11772.45
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [27.72463768115942, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - VEDOLIZUMAB

average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 27.7 times with a 7.3 weekly interval (202.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - axial spondyloarthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - axial spondyloarthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2266.81
first_seen: 2021-09-02T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2021-09-02
last_seen_parent: 2025-12-19
average_administered: [10.444444444444445, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.4 times with a 9.3 weekly interval (97.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4843.33
first_seen: 2019-07-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-07-11
last_seen_parent: 2025-12-31
average_administered: [7.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 7.0 times with a 11.4 weekly interval (80.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
labels: ADALIMUMAB
cost_pp_pa: 1963.37
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [26.627659574468087, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26.6 times with a 9.0 weekly interval (239.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - IXEKIZUMAB
labels: IXEKIZUMAB
cost_pp_pa: 9317.1
first_seen: 2023-07-19T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2023-07-19
last_seen_parent: 2025-12-19
average_administered: [8.166666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>IXEKIZUMAB</b><br>On average given 8.2 times with a 12.4 weekly interval (102.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1261.33
first_seen: 2023-05-26T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2023-05-26
last_seen_parent: 2025-12-22
average_administered: [7.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7.3 times with a 10.0 weekly interval (73.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 4848.83
first_seen: 2019-07-11T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-07-11
last_seen_parent: 2025-12-23
average_administered: [28.666666666666668, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 28.7 times with a 9.6 weekly interval (275.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 8639.4
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-29
average_administered: [41.333333333333336, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 41.3 times with a 4.0 weekly interval (165.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ankylosing spondylitis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ankylosing spondylitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2444.59
first_seen: 2019-09-17T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-05-31
last_seen_parent: 2025-12-31
average_administered: [19.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ankylosing spondylitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19.4 times with a 11.3 weekly interval (219.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3715.85
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [31.10566037735849, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 31.1 times with a 7.7 weekly interval (240.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 7362.29
first_seen: 2019-06-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-17
last_seen_parent: 2025-12-30
average_administered: [11.810344827586206, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 11.8 times with a 11.9 weekly interval (140.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 4199.4
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-11
average_administered: [31.333333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 31.3 times with a 4.7 weekly interval (148.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis
labels: DUPILUMAB
cost_pp_pa: 7612.4
first_seen: 2022-08-12T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2022-08-12
last_seen_parent: 2025-11-25
average_administered: [7.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: atopic dermatitis
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis - DUPILUMAB

average_spacing:
<br><b>DUPILUMAB</b><br>On average given 7.5 times with a 10.4 weekly interval (78.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2729.05
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [17.665137614678898, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 17.7 times with a 11.4 weekly interval (202.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 2370.48
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-24
average_administered: [29.902439024390244, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 29.9 times with a 7.4 weekly interval (222.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: RITUXIMAB
cost_pp_pa: 2933.47
first_seen: 2019-05-02T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-05-02
last_seen_parent: 2025-12-18
average_administered: [6.033333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 6.0 times with a 27.4 weekly interval (165.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: SECUKINUMAB
cost_pp_pa: 5164.74
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-29
average_administered: [26.464285714285715, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - SECUKINUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 26.5 times with a 10.1 weekly interval (269.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: TOCILIZUMAB
cost_pp_pa: 7247.78
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [56.45454545454545, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - TOCILIZUMAB

average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 56.5 times with a 5.4 weekly interval (307.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ankylosing spondylitis
labels: ADALIMUMAB
cost_pp_pa: 1705.03
first_seen: 2019-04-07T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-07
last_seen_parent: 2025-12-29
average_administered: [35.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ankylosing spondylitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ankylosing spondylitis - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 35.4 times with a 9.3 weekly interval (329.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 2005.11
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [31.73818181818182, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 31.7 times with a 8.7 weekly interval (276.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: BARICITINIB
cost_pp_pa: 4610.64
first_seen: 2019-05-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-30
last_seen_parent: 2025-12-30
average_administered: [17.857142857142858, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - BARICITINIB

average_spacing:
<br><b>BARICITINIB</b><br>On average given 17.9 times with a 11.4 weekly interval (205.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 8421.28
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-22
average_administered: [25.818181818181817, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 25.8 times with a 9.1 weekly interval (236.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: GOLIMUMAB
cost_pp_pa: 8309.86
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-30
average_administered: [34.92857142857143, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: GOLIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - GOLIMUMAB

average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 34.9 times with a 9.9 weekly interval (344.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: IMMUNOGLOBULIN
cost_pp_pa: 33787.49
first_seen: 2024-04-04T00:00:00
last_seen: 2025-09-24T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-09-24
average_administered: [22.833333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 22.8 times with a 2.4 weekly interval (55.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4651.26
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-31
average_administered: [18.76595744680851, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 18.8 times with a 5.6 weekly interval (105.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 12127.79
first_seen: 2019-04-05T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-05
last_seen_parent: 2025-12-31
average_administered: [20.3, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 20.3 times with a 6.6 weekly interval (133.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2767.8
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [18.390625, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 18.4 times with a 12.0 weekly interval (221.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4417.03
first_seen: 2024-01-25T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-01-25
last_seen_parent: 2025-12-31
average_administered: [5.818181818181818, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.8 times with a 5.4 weekly interval (31.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 293824.89
first_seen: 2025-10-17T00:00:00
last_seen: 2025-12-03T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-08
average_administered: [1.3333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 1.3 times with a 1.6 weekly interval (2.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - follicular lymphoma
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - follicular lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 5518.62
first_seen: 2024-06-20T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-06-20
last_seen_parent: 2025-12-31
average_administered: [7.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7.0 times with a 3.9 weekly interval (27.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx)
labels: DIMETHYL FUMARATE
cost_pp_pa: 2016.5
first_seen: 2024-04-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-29
average_administered: [7.2631578947368425, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY (no GP dx)
drug_sequence: DIMETHYL FUMARATE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx) - DIMETHYL FUMARATE

average_spacing:
<br><b>DIMETHYL FUMARATE</b><br>On average given 7.3 times with a 12.1 weekly interval (89.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx)
labels: FREMANEZUMAB
cost_pp_pa: 2819.9
first_seen: 2021-06-01T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2021-06-01
last_seen_parent: 2025-12-23
average_administered: [15.178571428571429, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY (no GP dx)
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx) - FREMANEZUMAB

average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 15.2 times with a 13.4 weekly interval (204.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx)
labels: IMMUNOGLOBULIN
cost_pp_pa: 58801.79
first_seen: 2024-04-03T00:00:00
last_seen: 2025-09-24T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-10-30
average_administered: [24.78125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY (no GP dx)
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx) - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 24.8 times with a 3.7 weekly interval (92.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: AFLIBERCEPT
cost_pp_pa: 2940.58
first_seen: 2019-04-22T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-24
average_administered: [21.272727272727273, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21.3 times with a 10.7 weekly interval (228.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: BEVACIZUMAB
cost_pp_pa: 221.74
first_seen: 2021-02-01T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2021-02-01
last_seen_parent: 2025-12-31
average_administered: [3.142857142857143, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 3.1 times with a 14.4 weekly interval (45.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: GOLIMUMAB
cost_pp_pa: 9062.26
first_seen: 2019-05-14T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-23
average_administered: [49.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: GOLIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx)

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - GOLIMUMAB

average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 49.0 times with a 4.9 weekly interval (238.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: INFLIXIMAB
cost_pp_pa: 4632.69
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [21.610169491525422, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx)

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 21.6 times with a 6.1 weekly interval (133.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: RISANKIZUMAB
cost_pp_pa: 18014.1
first_seen: 2024-05-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-05-02
last_seen_parent: 2025-12-31
average_administered: [6.681818181818182, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx)

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - RISANKIZUMAB

average_spacing:
<br><b>RISANKIZUMAB</b><br>On average given 6.7 times with a 6.1 weekly interval (41.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: VEDOLIZUMAB
cost_pp_pa: 11715.74
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [23.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - VEDOLIZUMAB

average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 23.6 times with a 7.3 weekly interval (172.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 1926.58
first_seen: 2020-04-01T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-12-31
average_administered: [11.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: plaque psoriasis
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 11.8 times with a 17.0 weekly interval (201.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8062.06
first_seen: 2019-04-08T00:00:00
last_seen: 2025-11-20T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-11-20
average_administered: [21.571428571428573, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: plaque psoriasis
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 21.6 times with a 11.9 weekly interval (256.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: ADALIMUMAB
cost_pp_pa: 2544.8
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [35.518181818181816, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 35.5 times with a 8.3 weekly interval (294.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3789.28
first_seen: 2023-11-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2023-11-03
last_seen_parent: 2025-12-31
average_administered: [5.688311688311688, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.7 times with a 6.4 weekly interval (37.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 34536.05
first_seen: 2024-10-25T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [2.2222222222222223, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.2 times with a 3.9 weekly interval (8.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - migraine
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - migraine - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 3135.42
first_seen: 2021-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-02-12
last_seen_parent: 2025-12-30
average_administered: [14.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: migraine
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 14.5 times with a 8.6 weekly interval (124.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - migraine
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - migraine - GALCANEZUMAB
labels: GALCANEZUMAB
cost_pp_pa: 2799.69
first_seen: 2022-01-17T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2022-01-17
last_seen_parent: 2025-12-19
average_administered: [18.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: migraine
drug_sequence: GALCANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GALCANEZUMAB</b><br>On average given 18.5 times with a 7.7 weekly interval (143.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ovarian cancer
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ovarian cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 7469.42
first_seen: 2025-02-27T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-27
last_seen_parent: 2025-12-31
average_administered: [7.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ovarian cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 7.6 times with a 3.0 weekly interval (23.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3003.74
first_seen: 2020-01-07T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2020-01-07
last_seen_parent: 2025-12-31
average_administered: [9.243243243243244, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.2 times with a 10.0 weekly interval (92.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - APREMILAST
labels: APREMILAST
cost_pp_pa: 5381.51
first_seen: 2019-05-30T00:00:00
last_seen: 2025-10-13T00:00:00
first_seen_parent: 2019-05-30
last_seen_parent: 2025-12-19
average_administered: [23.333333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: plaque psoriasis
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>APREMILAST</b><br>On average given 23.3 times with a 11.7 weekly interval (273.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY (no GP dx)
labels: OCTREOTIDE
cost_pp_pa: 5657.77
first_seen: 2024-04-11T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-04-11
last_seen_parent: 2025-12-11
average_administered: [11.833333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ENDOCRINOLOGY (no GP dx)
drug_sequence: OCTREOTIDE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY (no GP dx) - OCTREOTIDE

average_spacing:
<br><b>OCTREOTIDE</b><br>On average given 11.8 times with a 4.9 weekly interval (57.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2781.5
first_seen: 2020-06-08T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2020-05-29
last_seen_parent: 2025-12-31
average_administered: [14.18918918918919, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.2 times with a 8.3 weekly interval (118.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 6498.97
first_seen: 2019-04-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-10
last_seen_parent: 2025-12-30
average_administered: [12.88888888888889, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ulcerative colitis
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 12.9 times with a 9.4 weekly interval (122.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - uveitis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2527.43
first_seen: 2019-04-18T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-04-18
last_seen_parent: 2025-11-27
average_administered: [21.285714285714285, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: uveitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21.3 times with a 6.1 weekly interval (131.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: OMALIZUMAB
cost_pp_pa: 4127.85
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-30
average_administered: [28.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - OMALIZUMAB

average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 28.0 times with a 4.9 weekly interval (136.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: SECUKINUMAB
cost_pp_pa: 8799.18
first_seen: 2019-04-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-17
last_seen_parent: 2025-12-30
average_administered: [12.625, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - SECUKINUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 12.6 times with a 13.1 weekly interval (166.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: 4259.33
first_seen: 2019-06-12T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-12
last_seen_parent: 2025-12-24
average_administered: [19.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BARICITINIB</b><br>On average given 19.2 times with a 13.6 weekly interval (261.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1812.67
first_seen: 2023-01-30T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2023-01-30
last_seen_parent: 2025-12-29
average_administered: [5.454545454545454, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.5 times with a 10.9 weekly interval (60.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 11438.9
first_seen: 2020-12-03T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-29
average_administered: [23.285714285714285, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 23.3 times with a 6.1 weekly interval (143.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: DUPILUMAB
cost_pp_pa: 7751.25
first_seen: 2019-06-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-17
last_seen_parent: 2025-12-30
average_administered: [9.444444444444445, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - DUPILUMAB

average_spacing:
<br><b>DUPILUMAB</b><br>On average given 9.4 times with a 12.4 weekly interval (117.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: RANIBIZUMAB
cost_pp_pa: 2826.2
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [13.822429906542055, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 13.8 times with a 9.1 weekly interval (126.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - prostate cancer
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - prostate cancer - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1228.07
first_seen: 2025-01-22T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-01-22
last_seen_parent: 2025-12-29
average_administered: [4.538461538461538, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: prostate cancer
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 4.5 times with a 2.9 weekly interval (13.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - psoriatic arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - psoriatic arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1100.31
first_seen: 2021-02-23T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2021-02-23
last_seen_parent: 2025-12-11
average_administered: [17.125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: psoriatic arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17.1 times with a 10.4 weekly interval (178.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - psoriatic arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4318.31
first_seen: 2024-06-26T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2024-06-26
last_seen_parent: 2025-12-17
average_administered: [6.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: psoriatic arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6.8 times with a 12.3 weekly interval (84.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2130.9
first_seen: 2019-04-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-10
last_seen_parent: 2025-12-31
average_administered: [9.969072164948454, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.0 times with a 10.3 weekly interval (103.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: IMMUNOGLOBULIN
cost_pp_pa: 35057.52
first_seen: 2024-04-10T00:00:00
last_seen: 2025-09-24T00:00:00
first_seen_parent: 2024-04-10
last_seen_parent: 2025-09-24
average_administered: [38.333333333333336, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL IMMUNOLOGY (no GP dx)
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY (no GP dx)

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY (no GP dx) - IMMUNOGLOBULIN


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 2513.6
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-16
average_administered: [18.107142857142858, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18.1 times with a 9.9 weekly interval (178.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: APREMILAST
cost_pp_pa: 4062.49
first_seen: 2019-04-16T00:00:00
last_seen: 2025-12-12T00:00:00
first_seen_parent: 2019-04-16
last_seen_parent: 2025-12-12
average_administered: [11.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - APREMILAST

average_spacing:
<br><b>APREMILAST</b><br>On average given 11.8 times with a 13.4 weekly interval (158.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: ALIROCUMAB
cost_pp_pa: 2230.04
first_seen: 2022-10-21T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2022-10-21
last_seen_parent: 2025-12-30
average_administered: [14.555555555555555, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY (no GP dx)
drug_sequence: ALIROCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY (no GP dx)

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY (no GP dx) - ALIROCUMAB

average_spacing:
<br><b>ALIROCUMAB</b><br>On average given 14.6 times with a 7.3 weekly interval (106.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: EVOLOCUMAB
cost_pp_pa: 1864.82
first_seen: 2019-04-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-30
average_administered: [49.58695652173913, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY (no GP dx)
drug_sequence: EVOLOCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY (no GP dx)

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY (no GP dx) - EVOLOCUMAB

average_spacing:
<br><b>EVOLOCUMAB</b><br>On average given 49.6 times with a 4.9 weekly interval (241.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: ACALABRUTINIB
cost_pp_pa: 31741.64
first_seen: 2024-04-09T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2024-04-09
last_seen_parent: 2025-12-22
average_administered: [17.692307692307693, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx)

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 17.7 times with a 4.3 weekly interval (76.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: IMMUNOGLOBULIN
cost_pp_pa: 20298.91
first_seen: 2024-04-05T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2024-04-05
last_seen_parent: 2025-09-26
average_administered: [20.666666666666668, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx)

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 20.7 times with a 3.0 weekly interval (62.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
labels: RITUXIMAB
cost_pp_pa: 6933.01
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-31
average_administered: [9.818181818181818, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx)

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9.8 times with a 2.1 weekly interval (21.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3343.97
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [23.87719298245614, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23.9 times with a 8.7 weekly interval (208.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 6776.07
first_seen: 2021-04-29T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2021-04-29
last_seen_parent: 2025-12-29
average_administered: [8.461538461538462, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 8.5 times with a 9.0 weekly interval (76.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1845.49
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-29
average_administered: [28.73913043478261, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: uveitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28.7 times with a 9.1 weekly interval (262.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1887.51
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-31
average_administered: [12.882352941176471, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12.9 times with a 18.0 weekly interval (232.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 8920.45
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-04
last_seen_parent: 2025-12-31
average_administered: [189.07692307692307, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 189.1 times with a 1.9 weekly interval (351.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3780.09
first_seen: 2023-04-12T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2023-04-12
last_seen_parent: 2025-12-17
average_administered: [7.111111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 7.1 times with a 10.4 weekly interval (74.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3110.78
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-31
average_administered: [14.7, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 14.7 times with a 10.3 weekly interval (151.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4516.16
first_seen: 2022-12-23T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2022-12-23
last_seen_parent: 2025-12-29
average_administered: [8.933333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 8.9 times with a 7.7 weekly interval (69.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1959.39
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [21.98076923076923, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22.0 times with a 9.4 weekly interval (207.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: 5737.14
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-18
average_administered: [60.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BARICITINIB</b><br>On average given 60.2 times with a 5.3 weekly interval (318.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 9316.23
first_seen: 2019-07-15T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-07-15
last_seen_parent: 2025-12-24
average_administered: [34.09090909090909, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 34.1 times with a 9.3 weekly interval (317.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - arthritis
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3974.52
first_seen: 2019-04-09T00:00:00
last_seen: 2025-11-04T00:00:00
first_seen_parent: 2019-04-09
last_seen_parent: 2025-11-04
average_administered: [24.428571428571427, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 24.4 times with a 12.7 weekly interval (310.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3048.26
first_seen: 2019-04-12T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-12
last_seen_parent: 2025-12-29
average_administered: [19.142857142857142, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 19.1 times with a 5.3 weekly interval (101.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 12393.84
first_seen: 2019-11-05T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-11-05
last_seen_parent: 2025-12-29
average_administered: [14.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 14.0 times with a 8.1 weekly interval (114.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2627.8
first_seen: 2019-12-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-12-03
last_seen_parent: 2025-12-30
average_administered: [8.3, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 8.3 times with a 10.3 weekly interval (85.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8116.78
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-24
average_administered: [23.916666666666668, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 23.9 times with a 12.9 weekly interval (307.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - prostate cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - prostate cancer - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 306.26
first_seen: 2025-02-20T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-20
last_seen_parent: 2025-12-29
average_administered: [6.411764705882353, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: prostate cancer
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 6.4 times with a 2.1 weekly interval (14.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1739.9
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-29
average_administered: [15.727272727272727, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15.7 times with a 11.4 weekly interval (179.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4515.78
first_seen: 2019-06-14T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-14
last_seen_parent: 2025-12-24
average_administered: [16.88888888888889, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 16.9 times with a 6.7 weekly interval (113.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion
labels: DEXAMETHASONE
cost_pp_pa: 2476.47
first_seen: 2019-08-23T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-08-23
last_seen_parent: 2025-12-31
average_administered: [2.3, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: retinal vein occlusion
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion - DEXAMETHASONE

average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 2.3 times with a 22.3 weekly interval (51.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2121.81
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-04
last_seen_parent: 2025-12-29
average_administered: [13.880952380952381, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13.9 times with a 10.1 weekly interval (141.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - APREMILAST
labels: APREMILAST
cost_pp_pa: 12276.59
first_seen: 2023-02-08T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-09-19
last_seen_parent: 2025-12-23
average_administered: [8.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>APREMILAST</b><br>On average given 8.0 times with a 10.4 weekly interval (83.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 7890.48
first_seen: 2021-05-24T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-10-08
average_administered: [16.166666666666668, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 16.2 times with a 11.4 weekly interval (185.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: USTEKINUMAB
cost_pp_pa: 8791.71
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-19
average_administered: [29.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - USTEKINUMAB

average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 29.2 times with a 11.7 weekly interval (342.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 2161.5
first_seen: 2019-06-27T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-27
last_seen_parent: 2025-12-24
average_administered: [22.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22.5 times with a 9.6 weekly interval (215.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: DIMETHYL FUMARATE
cost_pp_pa: 188997.32
first_seen: 2025-10-17T00:00:00
last_seen: 2025-11-21T00:00:00
first_seen_parent: 2019-06-08
last_seen_parent: 2025-12-23
average_administered: [2.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: DIMETHYL FUMARATE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - DIMETHYL FUMARATE

average_spacing:
<br><b>DIMETHYL FUMARATE</b><br>On average given 2.5 times with a 1.3 weekly interval (3.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 7629.66
first_seen: 2023-07-06T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2023-07-06
last_seen_parent: 2025-12-24
average_administered: [8.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 8.8 times with a 8.6 weekly interval (75.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - colorectal cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 323.21
first_seen: 2019-06-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-12-30
average_administered: [18.266666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: colorectal cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 18.3 times with a 10.1 weekly interval (186.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 10544.89
first_seen: 2019-06-21T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-21
last_seen_parent: 2025-12-31
average_administered: [35.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 35.0 times with a 7.4 weekly interval (260.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4533.79
first_seen: 2023-04-18T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2023-04-18
last_seen_parent: 2025-12-30
average_administered: [7.84, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 7.8 times with a 7.0 weekly interval (55.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 3229.47
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [9.090551181102363, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9.1 times with a 10.6 weekly interval (96.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2999.24
first_seen: 2024-02-12T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2023-01-24
last_seen_parent: 2025-09-26
average_administered: [4.166666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: migraine
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 4.2 times with a 21.3 weekly interval (89.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine - GALCANEZUMAB
labels: GALCANEZUMAB
cost_pp_pa: 1768.89
first_seen: 2022-01-11T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2022-01-11
last_seen_parent: 2025-09-26
average_administered: [9.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: migraine
drug_sequence: GALCANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GALCANEZUMAB</b><br>On average given 9.8 times with a 19.4 weekly interval (190.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 2384.51
first_seen: 2021-06-16T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-06-16
last_seen_parent: 2025-12-30
average_administered: [12.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ovarian cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 12.8 times with a 2.7 weekly interval (35.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia
labels: ACALABRUTINIB
cost_pp_pa: 26201.47
first_seen: 2021-05-06T00:00:00
last_seen: 2025-12-01T00:00:00
first_seen_parent: 2021-05-06
last_seen_parent: 2025-12-30
average_administered: [7.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 7.0 times with a 10.9 weekly interval (76.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia
labels: RITUXIMAB
cost_pp_pa: 3912.7
first_seen: 2019-07-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-07-04
last_seen_parent: 2025-12-31
average_administered: [11.45, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11.4 times with a 3.6 weekly interval (41.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 9633.86
first_seen: 2023-05-24T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-12-31
average_administered: [2.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 2.0 times with a 15.4 weekly interval (31.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 5503.49
first_seen: 2024-01-15T00:00:00
last_seen: 2025-12-26T00:00:00
first_seen_parent: 2023-12-22
last_seen_parent: 2025-12-26
average_administered: [5.461538461538462, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.5 times with a 5.6 weekly interval (31.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 2923.66
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [9.81547619047619, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9.8 times with a 12.1 weekly interval (119.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2831.42
first_seen: 2024-10-15T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-10-15
last_seen_parent: 2025-12-19
average_administered: [12.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12.5 times with a 1.9 weekly interval (23.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - hepatocellular carcinoma
labels: ATEZOLIZUMAB
cost_pp_pa: 20477.51
first_seen: 2022-12-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2022-12-06
last_seen_parent: 2025-12-30
average_administered: [11.91304347826087, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: hepatocellular carcinoma
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - hepatocellular carcinoma - ATEZOLIZUMAB

average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 11.9 times with a 3.4 weekly interval (41.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - lung cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - lung cancer - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 21981.14
first_seen: 2025-03-14T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-03-14
last_seen_parent: 2025-12-30
average_administered: [7.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: lung cancer
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 7.4 times with a 3.4 weekly interval (25.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3138.25
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [23.78102189781022, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 23.8 times with a 11.4 weekly interval (272.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3561.84
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [20.716666666666665, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20.7 times with a 11.9 weekly interval (245.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: AFLIBERCEPT
cost_pp_pa: 3655.72
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-27T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-27
average_administered: [22.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 22.0 times with a 9.9 weekly interval (217.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: BEVACIZUMAB
cost_pp_pa: 305.9
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-26T00:00:00
first_seen_parent: 2019-06-04
last_seen_parent: 2025-12-26
average_administered: [15.474576271186441, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 15.5 times with a 10.6 weekly interval (164.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: RANIBIZUMAB
cost_pp_pa: 4856.64
first_seen: 2019-07-31T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-24
last_seen_parent: 2025-12-30
average_administered: [6.354838709677419, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6.4 times with a 7.4 weekly interval (48.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: USTEKINUMAB
cost_pp_pa: N/A
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-08
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - USTEKINUMAB


date_filter_id: all_6mo
chart_type: indication
labels: USTEKINUMAB
cost_pp_pa: N/A
first_seen_parent: 2019-04-30
last_seen_parent: 2025-12-30
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - USTEKINUMAB


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 4294.52
first_seen: 2019-06-05T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-12-31
average_administered: [21.55, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 21.6 times with a 6.7 weekly interval (145.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx)
labels: RISANKIZUMAB
cost_pp_pa: 11912.19
first_seen: 2024-06-12T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-06-12
last_seen_parent: 2025-12-24
average_administered: [3.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - RISANKIZUMAB

average_spacing:
<br><b>RISANKIZUMAB</b><br>On average given 3.6 times with a 12.0 weekly interval (43.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3958.74
first_seen: 2019-06-05T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-12-30
average_administered: [26.395833333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 26.4 times with a 8.6 weekly interval (226.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 7752.94
first_seen: 2019-12-30T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-12-30
last_seen_parent: 2025-12-29
average_administered: [11.71875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 11.7 times with a 9.0 weekly interval (105.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 7622.31
first_seen: 2019-09-18T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-09-18
last_seen_parent: 2025-12-24
average_administered: [10.461538461538462, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: atopic dermatitis
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 10.5 times with a 9.0 weekly interval (94.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
labels: ADALIMUMAB
cost_pp_pa: 1577.7
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-19
average_administered: [23.444444444444443, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23.4 times with a 10.4 weekly interval (244.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 288.64
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-30
average_administered: [16.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: breast cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 16.2 times with a 9.1 weekly interval (148.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 3449.03
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-29
average_administered: [37.857142857142854, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 37.9 times with a 8.6 weekly interval (325.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 7113.8
first_seen: 2019-07-12T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-07-05
last_seen_parent: 2025-12-19
average_administered: [25.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 25.4 times with a 19.1 weekly interval (486.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: ETANERCEPT
cost_pp_pa: 3955.93
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-24
average_administered: [25.142857142857142, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ETANERCEPT

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 25.1 times with a 8.0 weekly interval (201.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 3875.59
first_seen: 2019-06-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-28
last_seen_parent: 2025-12-31
average_administered: [23.11111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 23.1 times with a 6.1 weekly interval (142.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: RITUXIMAB
cost_pp_pa: 1746.89
first_seen: 2019-09-28T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-09-28
last_seen_parent: 2025-12-30
average_administered: [12.428571428571429, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12.4 times with a 11.9 weekly interval (147.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 2126.14
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [24.35483870967742, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 24.4 times with a 9.0 weekly interval (220.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2073.51
first_seen: 2019-06-06T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-11-25
average_administered: [10.882352941176471, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.9 times with a 9.6 weekly interval (104.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3065.27
first_seen: 2022-12-02T00:00:00
last_seen: 2025-10-22T00:00:00
first_seen_parent: 2021-02-22
last_seen_parent: 2025-11-10
average_administered: [7.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.0 times with a 8.6 weekly interval (60.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4089.78
first_seen: 2019-06-27T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-06-27
last_seen_parent: 2025-11-27
average_administered: [18.53846153846154, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 18.5 times with a 6.4 weekly interval (119.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3461.21
first_seen: 2019-06-07T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-11-27
average_administered: [22.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 22.2 times with a 9.9 weekly interval (219.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4786.37
first_seen: 2022-09-01T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2022-09-01
last_seen_parent: 2025-11-27
average_administered: [20.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 20.2 times with a 5.9 weekly interval (118.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: ABATACEPT
cost_pp_pa: 3545.0
first_seen: 2019-07-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-30
average_administered: [14.666666666666666, 6.0, 5.333333333333333, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|RITUXIMAB|ABATACEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - RITUXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - RITUXIMAB - ABATACEPT

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.7 times with a 2.6 weekly interval (38.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 6.0 times with a 95.9 weekly interval (575.0 weeks total treatment length)<br><b>ABATACEPT</b><br>On average given 5.3 times with a 50.6 weekly interval (268.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: TOCILIZUMAB
cost_pp_pa: 3504.56
first_seen: 2019-04-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-15
last_seen_parent: 2025-12-30
average_administered: [8.25, 2.875, 19.125, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|RITUXIMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - RITUXIMAB - TOCILIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.2 times with a 10.6 weekly interval (87.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 2.9 times with a 6.0 weekly interval (17.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 19.1 times with a 4.4 weekly interval (85.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 3659.05
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-31
average_administered: [16.1875, 10.625, 11.8125, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - AFLIBERCEPT

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 16.2 times with a 15.3 weekly interval (248.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 10.6 times with a 14.4 weekly interval (153.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 11.8 times with a 9.3 weekly interval (110.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer
labels: BEVACIZUMAB
cost_pp_pa: 191.38
first_seen: 2020-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2020-04-03
last_seen_parent: 2025-12-31
average_administered: [3.782608695652174, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: non-small-cell lung cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 3.8 times with a 15.0 weekly interval (57.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer
labels: BEVACIZUMAB
cost_pp_pa: 300.83
first_seen: 2019-06-13T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-13
last_seen_parent: 2025-12-30
average_administered: [20.94, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: non-small-cell lung cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20.9 times with a 15.3 weekly interval (319.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 5050.05
first_seen: 2019-06-14T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2019-06-14
last_seen_parent: 2025-12-21
average_administered: [20.88888888888889, 13.222222222222221, 20.0, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - AFLIBERCEPT

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 20.9 times with a 7.4 weekly interval (155.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 13.2 times with a 9.9 weekly interval (130.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 20.0 times with a 4.9 weekly interval (97.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: UPADACITINIB
cost_pp_pa: 4587.98
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [6.818181818181818, 6.818181818181818, 6.545454545454546, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB|USTEKINUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB - USTEKINUMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB - USTEKINUMAB - UPADACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.8 times with a 8.0 weekly interval (54.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 6.8 times with a 20.7 weekly interval (141.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 6.5 times with a 25.1 weekly interval (163.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2138.62
first_seen: 2019-04-18T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-18
last_seen_parent: 2025-12-22
average_administered: [12.75, 12.25, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 12.8 times with a 29.0 weekly interval (371.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 12.2 times with a 36.7 weekly interval (448.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 2546.72
first_seen: 2019-04-09T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-09
last_seen_parent: 2025-12-29
average_administered: [14.1, 2.8, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 14.1 times with a 11.1 weekly interval (157.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 2.8 times with a 21.4 weekly interval (60.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 2977.59
first_seen: 2019-04-09T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-09
last_seen_parent: 2025-12-29
average_administered: [20.705882352941178, 6.372549019607843, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20.7 times with a 8.9 weekly interval (183.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 6.4 times with a 5.1 weekly interval (33.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: TOFACITINIB
cost_pp_pa: 4668.37
first_seen: 2019-04-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-07
last_seen_parent: 2025-12-30
average_administered: [8.666666666666666, 25.133333333333333, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB - TOFACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.7 times with a 7.7 weekly interval (67.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 25.1 times with a 8.6 weekly interval (215.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: UPADACITINIB
cost_pp_pa: 4102.16
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-22
average_administered: [10.5, 9.461538461538462, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB - UPADACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.5 times with a 6.7 weekly interval (70.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 9.5 times with a 8.1 weekly interval (77.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: INFLIXIMAB
cost_pp_pa: 3466.33
first_seen: 2019-05-06T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2019-04-24
last_seen_parent: 2025-12-16
average_administered: [23.333333333333332, 9.333333333333334, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB - INFLIXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23.3 times with a 8.4 weekly interval (196.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 9.3 times with a 7.0 weekly interval (65.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: ADALIMUMAB
cost_pp_pa: 4085.48
first_seen: 2019-04-11T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-23
average_administered: [28.0, 6.75, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB - ADALIMUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 28.0 times with a 3.0 weekly interval (84.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 6.8 times with a 16.9 weekly interval (115.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1629.36
first_seen: 2021-02-04T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2021-02-04
last_seen_parent: 2025-12-22
average_administered: [6.1, 4.4, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.1 times with a 7.9 weekly interval (48.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 4.4 times with a 8.1 weekly interval (36.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 4585.81
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-10T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-29
average_administered: [9.285714285714286, 23.714285714285715, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.3 times with a 7.7 weekly interval (72.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 23.7 times with a 6.0 weekly interval (142.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 4205.94
first_seen: 2019-05-03T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2019-05-03
last_seen_parent: 2025-12-31
average_administered: [13.777777777777779, 6.222222222222222, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ulcerative colitis
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13.8 times with a 8.0 weekly interval (110.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 6.2 times with a 8.1 weekly interval (50.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: VEDOLIZUMAB
cost_pp_pa: 5508.64
first_seen: 2019-05-20T00:00:00
last_seen: 2025-12-04T00:00:00
first_seen_parent: 2019-05-20
last_seen_parent: 2025-12-04
average_administered: [7.25, 9.75, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB - VEDOLIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.2 times with a 6.1 weekly interval (44.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 9.8 times with a 5.0 weekly interval (49.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: DEXAMETHASONE
cost_pp_pa: 1941.8
first_seen: 2020-07-22T00:00:00
last_seen: 2025-12-09T00:00:00
first_seen_parent: 2020-07-22
last_seen_parent: 2025-12-09
average_administered: [3.4, 9.4, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB - DEXAMETHASONE

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.4 times with a 54.0 weekly interval (184.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 9.4 times with a 15.4 weekly interval (145.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 3178.74
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [6.366666666666666, 18.3, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6.4 times with a 47.3 weekly interval (303.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 18.3 times with a 4.1 weekly interval (76.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - AFLIBERCEPT - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 2845.17
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-23
average_administered: [23.263157894736842, 5.526315789473684, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 23.3 times with a 9.7 weekly interval (226.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 5.5 times with a 4.6 weekly interval (25.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - RANIBIZUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - RANIBIZUMAB - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 2201.03
first_seen: 2019-04-12T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-12
last_seen_parent: 2025-12-18
average_administered: [8.0, 15.4, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 8.0 times with a 19.7 weekly interval (158.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 15.4 times with a 11.4 weekly interval (176.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: AFLIBERCEPT
cost_pp_pa: 3218.02
first_seen: 2019-04-28T00:00:00
last_seen: 2025-11-14T00:00:00
first_seen_parent: 2019-04-28
last_seen_parent: 2025-11-14
average_administered: [17.75, 12.25, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 17.8 times with a 7.4 weekly interval (132.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 12.2 times with a 25.6 weekly interval (312.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - APREMILAST
labels: ADALIMUMAB
cost_pp_pa: 5066.61
first_seen: 2019-12-05T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-11-19
last_seen_parent: 2025-12-23
average_administered: [9.666666666666666, 7.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: APREMILAST|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - APREMILAST - ADALIMUMAB

average_spacing:
<br><b>APREMILAST</b><br>On average given 9.7 times with a 5.0 weekly interval (48.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 7.0 times with a 8.3 weekly interval (58.0 weeks total treatment length)


